| Name | Acadia Healthcare Company, Inc. |
|---|---|
| CIK | 0001520697 |
| Tickers | ACHC |
| Exchanges | Nasdaq |
| Entity type | operating |
| Category | Large accelerated filer |
| SIC | 8093 Services-Specialty Outpatient Facilities, NEC |
| EIN | 000000000 |
| LEI | — |
| Fiscal year end | 1231 |
| State of incorporation | DE DE |
| Phone | 615-861-6000 |
| Website | — |
| Investor website | — |
| Owner org | 08 Industrial Applications and Services |
| Flags | — |
| Description | — |
| Insider transactions (issuer) | 1 |
| Insider transactions (owner) | 0 |
EDGAR has no company-logo API. Website field is shown when the filer provided one.
No Financialist filing articles yet for this CIK.
1308 filing rows loaded from submissions recent; extra archives: CIK0001520697-submissions-001.json (308 filings, 2011-05-24 to 2014-01-27).
| Filed | Form | Document | Items | Accession | File no. | Film | Act | Size | XBRL | iXBRL |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-16 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0000902219-26-000351 | 005-86704 | 261557829 | 34 | 15534 | |||
| 2026-11-04 | 10-Q | 10-Q | 0001193125-26-447412 | 001-35331 | 261523008 | 34 | 11744902 | 1 | 1 | |
| 2026-11-04 | 8-K | FORM 8-K | 2.02,7.01,9.01 | 0001437749-26-034941 | 001-35331 | 261522279 | 34 | 2887468 | 1 | 1 |
| 2026-10-08 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0000354204-26-001066 | 005-86704 | 261449578 | 34 | 8711 | |||
| 2026-09-25 | 8-K | FORM 8-K | 8.01,9.01 | 0001437749-26-031225 | 001-35331 | 261410524 | 34 | 755124 | 1 | 1 |
| 2026-08-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001172661-26-003445 | 005-86704 | 261275930 | 34 | 12316 | |||
| 2026-08-13 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0000902219-26-000250 | 005-86704 | 261273329 | 34 | 17396 | |||
| 2026-08-06 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0000315066-26-001929 | 005-86704 | 261246901 | 34 | 11666 | |||
| 2026-07-28 | 8-K | FORM 8-K | 2.02,7.01,9.01 | 0001437749-26-024693 | 001-35331 | 261212761 | 34 | 3167027 | 1 | 1 |
| 2026-07-28 | 10-Q | 10-Q | 0001193125-26-321076 | 001-35331 | 261212292 | 34 | 11582469 | 1 | 1 | |
| 2026-07-27 | 4 | 4 | 0001193125-26-318240 | 4538 | ||||||
| 2026-07-27 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0002012383-26-002158 | 005-86704 | 261206023 | 34 | 11107 | |||
| 2026-06-26 | 4 | 4 | 0001193125-26-285667 | 4538 | ||||||
| 2026-05-18 | 8-K | 8-K | 8.01 | 0001193125-26-229138 | 001-35331 | 26994904 | 34 | 139833 | 1 | 1 |
| 2026-05-15 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001172661-26-002398 | 005-86704 | 26989659 | 34 | 12255 | |||
| 2026-05-15 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0000902219-26-000147 | 005-86704 | 26982221 | 34 | 17369 | |||
| 2026-05-11 | S-8 | S-8 | 0001193125-26-217120 | 333-295773 | 26964486 | 33 | 211805 | 1 | 1 | |
| 2026-05-11 | 3 | 3 | 0001193125-26-217089 | 15548 | ||||||
| 2026-05-11 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0000886982-26-000164 | 005-86704 | 26962065 | 34 | 18379 | |||
| 2026-05-08 | 4 | 4 | 0001193125-26-215070 | 4683 | ||||||
| 2026-05-08 | 4 | 4 | 0001193125-26-214932 | 4752 | ||||||
| 2026-05-08 | 4 | 4 | 0001193125-26-214931 | 4714 | ||||||
| 2026-05-08 | 4 | 4 | 0001193125-26-214930 | 6273 | ||||||
| 2026-05-08 | 4 | 4 | 0001193125-26-214929 | 4714 | ||||||
| 2026-05-08 | 4 | 4 | 0001193125-26-214927 | 4712 | ||||||
| 2026-05-08 | 4 | 4 | 0001193125-26-214926 | 4690 | ||||||
| 2026-05-08 | 4 | 4 | 0001193125-26-214925 | 8497 | ||||||
| 2026-05-08 | 4 | 4 | 0001193125-26-214924 | 6306 | ||||||
| 2026-05-06 | 4 | 4 | 0001193125-26-209423 | 4537 | ||||||
| 2026-05-06 | 8-K | 8-K | 5.07,9.01 | 0001193125-26-209324 | 001-35331 | 26949539 | 34 | 156779 | 1 | 1 |
| 2026-04-30 | 4 | 4 | 0001193125-26-198070 | 4740 | ||||||
| 2026-04-30 | 10-Q | 10-Q | 0001193125-26-192508 | 001-35331 | 26918514 | 34 | 10061320 | 1 | 1 | |
| 2026-04-29 | 8-K | FORM 8-K | 2.02,7.01,9.01 | 0001437749-26-013916 | 001-35331 | 26918155 | 34 | 2362236 | 1 | 1 |
| 2026-04-29 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0002100119-26-000123 | 005-86704 | 26916967 | 34 | 7452 | |||
| 2026-04-28 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0002100121-26-000063 | 005-86704 | 26907273 | 34 | 7396 | |||
| 2026-04-23 | 8-K | 8-K | 5.02,7.01,9.01 | 0001193125-26-173769 | 001-35331 | 26888955 | 34 | 320836 | 1 | 1 |
| 2026-04-13 | 4 | 4 | 0001193125-26-153040 | 4812 | ||||||
| 2026-04-13 | 4 | 4 | 0001193125-26-153039 | 4738 | ||||||
| 2026-03-26 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0000102909-26-000501 | 005-86704 | 26797267 | 34 | 7218 | |||
| 2026-03-25 | ARS | ARS | 0001140361-26-011134 | 001-35331 | 26793372 | 34 | 2797808 | |||
| 2026-03-25 | DEFA14A | DEFA14A | 0001140361-26-011132 | 001-35331 | 26793363 | 34 | 1282318 | |||
| 2026-03-25 | DEF 14A | DEF 14A | 0001140361-26-011130 | 001-35331 | 26793342 | 34 | 9082676 | 1 | 1 | |
| 2026-03-18 | 4 | 4 | 0001193125-26-114519 | 4675 | ||||||
| 2026-03-18 | 3 | 3 | 0001193125-26-114513 | 16413 | ||||||
| 2026-03-12 | 8-K | 8-K | 5.02,7.01,9.01 | 0001193125-26-104272 | 001-35331 | 26748296 | 34 | 181633 | 1 | 1 |
| 2026-03-11 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0001539497-26-000915 | 005-86704 | 26745471 | 34 | 12723 | |||
| 2026-02-27 | 4 | 4 | 0001193125-26-083110 | 4397 | ||||||
| 2026-02-27 | 10-K | 10-K | 0001193125-26-078266 | 001-35331 | 26691675 | 34 | 17864403 | 1 | 1 | |
| 2026-02-25 | 8-K | FORM 8-K | 2.02,7.01,9.01 | 0001437749-26-005431 | 001-35331 | 26674194 | 34 | 4325554 | 1 | 1 |
| 2026-02-12 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0000886982-26-000056 | 005-86704 | 26623907 | 34 | 18202 | |||
| 2026-02-10 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000902219-26-000089 | 005-86704 | 26614332 | 34 | 17272 | |||
| 2026-01-23 | SCHEDULE 13D/A | xslSCHEDULE_13D_X01/primary_doc.xml | 0001539497-26-000135 | 005-86704 | 26554845 | 34 | 29779 | |||
| 2026-01-23 | 8-K | 8-K | 5.02,9.01 | 0001193125-26-020169 | 001-35331 | 26553358 | 34 | 233489 | 1 | 1 |
| 2026-01-21 | 4 | 4 | 0001193125-26-018061 | 5965 | ||||||
| 2026-01-21 | 3 | 3 | 0001193125-26-018043 | 16326 | ||||||
| 2026-01-20 | 8-K | FORM 8-K | 5.02,7.01,9.01 | 0001437749-26-001486 | 001-35331 | 26541170 | 34 | 458005 | 1 | 1 |
| 2026-01-13 | 8-K | FORM 8-K | 2.02,7.01,9.01 | 0001437749-26-001137 | 001-35331 | 26528473 | 34 | 2021266 | 1 | 1 |
| 2025-12-02 | 8-K | FORM 8-K | 7.01,9.01 | 0001437749-25-036657 | 001-35331 | 251543256 | 34 | 210627 | 1 | 1 |
| 2025-11-24 | SCHEDULE 13D/A | xslSCHEDULE_13D_X01/primary_doc.xml | 0001539497-25-003053 | 005-86704 | 251514686 | 34 | 64165 | |||
| 2025-11-10 | 8-K | 8-K | 7.01,9.01 | 0001193125-25-274380 | 001-35331 | 251466724 | 34 | 143942 | 1 | 1 |
| 2025-11-05 | 10-Q | 10-Q | 0001193125-25-267062 | 001-35331 | 251454548 | 34 | 12154977 | 1 | 1 | |
| 2025-11-05 | 8-K | FORM 8-K | 2.02,5.02,9.01 | 0001437749-25-033347 | 001-35331 | 251454070 | 34 | 813000 | 1 | 1 |
| 2025-10-28 | 4 | 4 | 0001193125-25-253974 | 4676 | ||||||
| 2025-10-28 | 3 | 3 | 0001193125-25-253947 | 15253 | ||||||
| 2025-10-07 | 8-K | 8-K | 5.02,7.01,9.01 | 0001193125-25-233507 | 001-35331 | 251380085 | 34 | 321063 | 1 | 1 |
| 2025-10-06 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000102909-25-000015 | 005-86704 | 251377661 | 34 | 6261 | |||
| 2025-10-06 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000902219-25-000363 | 005-86704 | 251376189 | 34 | 17252 | |||
| 2025-10-02 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0002012383-25-001647 | 005-86704 | 251371443 | 34 | 11045 | |||
| 2025-10-01 | 4 | 4 | 0001193125-25-226935 | 4409 | ||||||
| 2025-10-01 | SCHEDULE 13D | xslSCHEDULE_13D_X01/primary_doc.xml | 0001539497-25-002580 | 005-86704 | 251364571 | 34 | 162294 | |||
| 2025-09-29 | 8-K | 8-K | 7.01 | 0001193125-25-221545 | 001-35331 | 251352084 | 34 | 142820 | 1 | 1 |
| 2025-08-25 | 3 | 3 | 0001193125-25-187817 | 20188 | ||||||
| 2025-08-12 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000902219-25-000278 | 005-86704 | 251204922 | 34 | 17248 | |||
| 2025-08-05 | 10-Q | 10-Q | 0000950170-25-103160 | 001-35331 | 251185701 | 34 | 11195215 | 1 | 1 | |
| 2025-08-05 | 8-K | FORM 8-K | 2.02,5.02,9.01 | 0001437749-25-024875 | 001-35331 | 251185523 | 34 | 741112 | 1 | 1 |
| 2025-07-29 | 4 | 4 | 0000950170-25-099722 | 4452 | ||||||
| 2025-07-29 | 4 | 4 | 0000950170-25-099721 | 4394 | ||||||
| 2025-06-27 | 4 | 4 | 0000950170-25-091002 | 4430 | ||||||
| 2025-06-27 | 4 | 4 | 0000950170-25-091001 | 4452 | ||||||
| 2025-06-27 | 4 | 4 | 0000950170-25-091000 | 4393 | ||||||
| 2025-05-30 | 4 | 4 | 0000950170-25-079852 | 4603 | ||||||
| 2025-05-30 | 4 | 4 | 0000950170-25-079851 | 4545 | ||||||
| 2025-05-30 | 4 | 4 | 0000950170-25-079850 | 4573 | ||||||
| 2025-05-30 | 4 | 4 | 0000950170-25-079848 | 8355 | ||||||
| 2025-05-30 | 4 | 4 | 0000950170-25-079849 | 6144 | ||||||
| 2025-05-30 | 4 | 4 | 0000950170-25-079847 | 4542 | ||||||
| 2025-05-30 | 4 | 4 | 0000950170-25-079845 | 6130 | ||||||
| 2025-05-30 | 4 | 4 | 0000950170-25-079846 | 6169 | ||||||
| 2025-05-30 | 4 | 4 | 0000950170-25-079844 | 4549 | ||||||
| 2025-05-30 | S-8 | S-8 | 0001140361-25-020960 | 333-287698 | 251011990 | 33 | 292178 | 1 | 1 | |
| 2025-05-30 | 8-K | 8-K | 5.07,9.01 | 0001193125-25-132208 | 001-35331 | 251011476 | 34 | 160489 | 1 | 1 |
| 2025-05-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001897612-25-000201 | 005-86704 | 25943484 | 34 | 7690 | |||
| 2025-05-13 | 4 | 4 | 0000950170-25-070507 | 4429 | ||||||
| 2025-05-12 | 8-K | FORM 8-K | 2.02,9.01 | 0001437749-25-016141 | 001-35331 | 25935502 | 34 | 563317 | 1 | 1 |
| 2025-05-12 | 10-Q | 10-Q | 0000950170-25-069294 | 001-35331 | 25935356 | 34 | 9893231 | 1 | 1 | |
| 2025-05-07 | 4 | 4 | 0000950170-25-066062 | 4651 | ||||||
| 2025-05-07 | 4 | 4 | 0000950170-25-066037 | 4593 | ||||||
| 2025-05-07 | 4 | 4 | 0000950170-25-066035 | 4609 | ||||||
| 2025-05-07 | 4 | 4 | 0000950170-25-066028 | 6107 | ||||||
| 2025-04-11 | 4 | 4 | 0000950170-25-053363 | 4429 | ||||||
| 2025-04-10 | ARS | ARS | 0001140361-25-013296 | 001-35331 | 25829133 | 34 | 2331702 | |||
| 2025-04-10 | DEFA14A | DEFA14A | 0001140361-25-013295 | 001-35331 | 25829126 | 34 | 300863 | |||
| 2025-04-10 | DEF 14A | DEF 14A | 0001140361-25-013294 | 001-35331 | 25829110 | 34 | 3500113 | 1 | 1 | |
| 2025-03-10 | 8-K | 8-K | 1.01,2.03,8.01,9.01 | 0001193125-25-051083 | 001-35331 | 25724788 | 34 | 1340803 | 1 | 1 |
| 2025-03-03 | 4 | 4 | 0000950170-25-030983 | 4415 | ||||||
| 2025-02-28 | 4 | 4 | 0000950170-25-030198 | 4790 | ||||||
| 2025-02-28 | 4 | 4 | 0000950170-25-030197 | 4732 | ||||||
| 2025-02-28 | 4 | 4 | 0000950170-25-030196 | 7681 | ||||||
| 2025-02-28 | 8-K | 8-K | 1.01,1.02,2.03,9.01 | 0001193125-25-042573 | 001-35331 | 25691068 | 34 | 1425221 | 1 | 1 |
| 2025-02-27 | 10-K | 10-K | 0000950170-25-029095 | 001-35331 | 25679359 | 34 | 16492388 | 1 | 1 | |
| 2025-02-27 | 8-K | FORM 8-K | 2.02,9.01 | 0001437749-25-005467 | 001-35331 | 25678843 | 34 | 736636 | 1 | 1 |
| 2025-02-20 | UPLOAD | filename1.pdf | 0000000000-25-001991 | 001-35331 | 39826 | |||||
| 2025-02-18 | CORRESP | filename1.htm | 0001193125-25-028713 | 130441 | ||||||
| 2025-02-12 | UPLOAD | filename1.pdf | 0000000000-25-001611 | 001-35331 | 43443 | |||||
| 2025-02-12 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0000315066-25-000698 | 005-86704 | 25612288 | 34 | 11538 | |||
| 2025-01-21 | CORRESP | filename1.htm | 0001193125-25-009700 | 158693 | ||||||
| 2025-01-13 | 8-K | 8-K | 2.02 | 0001193125-25-005003 | 001-35331 | 25524883 | 34 | 143571 | 1 | 1 |
| 2024-12-23 | CORRESP | filename1.htm | 0001193125-24-284312 | 32136 | ||||||
| 2024-12-20 | UPLOAD | filename1.pdf | 0000000000-24-014133 | 001-35331 | 44422 | |||||
| 2024-12-06 | CORRESP | filename1.htm | 0001193125-24-272397 | 182836 | ||||||
| 2024-11-25 | CORRESP | filename1.htm | 0001193125-24-265343 | 31792 | ||||||
| 2024-11-15 | UPLOAD | filename1.pdf | 0000000000-24-012669 | 001-35331 | 45926 | |||||
| 2024-11-14 | SC 13G/A | achc13gasep24.txt | 0001897612-24-001935 | 005-86704 | 34 | 6565 | ||||
| 2024-11-12 | SC 13G/A | filing.txt | 0000315066-24-002664 | 005-86704 | 241444450 | 34 | 8406 | |||
| 2024-11-08 | 4 | 4 | 0000950170-24-124222 | 5782 | ||||||
| 2024-11-08 | SC 13G/A | SEC SCHEDULE 13G | 0000902219-24-000459 | 005-86704 | 241438668 | 34 | 36203 | |||
| 2024-10-30 | 8-K | FORM 8-K | 2.02,9.01 | 0001437749-24-032658 | 001-35331 | 241411536 | 34 | 679697 | 1 | 1 |
| 2024-10-30 | 10-Q | 10-Q | 0000950170-24-119044 | 001-35331 | 241410826 | 34 | 9399729 | 1 | 1 | |
| 2024-09-27 | 8-K | 8-K | 8.01 | 0001193125-24-227393 | 001-35331 | 241330632 | 34 | 146561 | 1 | 1 |
| 2024-08-30 | 144 | xsl144X01/primary_doc.xml | 0002002698-24-000349 | 001-35331 | 241270421 | 33 | 4874 | |||
| 2024-08-29 | 144 | xsl144X01/primary_doc.xml | 0002002698-24-000330 | 001-35331 | 241263676 | 33 | 4288 | |||
| 2024-08-08 | 144 | xsl144X01/primary_doc.xml | 0002007317-24-000533 | 001-35331 | 241188074 | 33 | 4277 | |||
| 2024-08-01 | 10-Q | 10-Q | 0000950170-24-089248 | 001-35331 | 241166547 | 34 | 9129421 | 1 | 1 | |
| 2024-07-31 | 8-K | FORM 8-K | 2.02,9.01 | 0001437749-24-024148 | 001-35331 | 241163082 | 34 | 621456 | 1 | 1 |
| 2024-07-29 | 4 | 4 | 0000950170-24-087347 | 4458 | ||||||
| 2024-07-29 | 4 | 4 | 0000950170-24-087346 | 4401 | ||||||
| 2024-07-01 | 3 | 3 | 0000950170-24-079729 | 14686 | ||||||
| 2024-06-28 | 4 | 4 | 0000950170-24-079132 | 4663 | ||||||
| 2024-06-28 | 4 | 4 | 0000950170-24-079131 | 4607 | ||||||
| 2024-06-28 | 4 | 4 | 0000950170-24-079130 | 4642 | ||||||
| 2024-06-06 | SC 13G/A | SEC SCHEDULE 13G | 0000902219-24-000308 | 005-86704 | 241024072 | 34 | 37907 | |||
| 2024-05-31 | 4 | 4 | 0000950170-24-067344 | 12758 | ||||||
| 2024-05-28 | 4 | 4 | 0000950170-24-065516 | 4556 | ||||||
| 2024-05-28 | 4 | 4 | 0000950170-24-065514 | 14066 | ||||||
| 2024-05-28 | 4 | 4 | 0000950170-24-065512 | 12494 | ||||||
| 2024-05-28 | 4 | 4 | 0000950170-24-065511 | 12712 | ||||||
| 2024-05-28 | 4 | 4 | 0000950170-24-065506 | 12744 | ||||||
| 2024-05-28 | 4 | 4 | 0000950170-24-065503 | 4555 | ||||||
| 2024-05-28 | 4 | 4 | 0000950170-24-065502 | 8364 | ||||||
| 2024-05-28 | 4 | 4 | 0000950170-24-065499 | 4553 | ||||||
| 2024-05-24 | 8-K | 8-K | 5.02,5.03,5.07,9.01 | 0001193125-24-146576 | 001-35331 | 24981141 | 34 | 495198 | 1 | 1 |
| 2024-05-10 | 4 | 4 | 0000950170-24-057973 | 4437 | ||||||
| 2024-05-10 | 4 | 4 | 0000950170-24-057972 | 4435 | ||||||
| 2024-05-02 | 10-Q | 10-Q | 0000950170-24-052085 | 001-35331 | 24908141 | 34 | 8365981 | 1 | 1 | |
| 2024-05-01 | 8-K | FORM 8-K | 2.02,9.01 | 0001437749-24-014205 | 001-35331 | 24904052 | 34 | 500982 | 1 | 1 |
| 2024-04-24 | 4 | 4 | 0000950170-24-047693 | 4437 | ||||||
| 2024-04-15 | 4 | 4 | 0000950170-24-044485 | 4437 | ||||||
| 2024-04-15 | 4 | 4 | 0000950170-24-044484 | 4435 | ||||||
| 2024-04-09 | ARS | ARS | 0001140361-24-018897 | 001-35331 | 24833473 | 34 | 2256617 | |||
| 2024-04-09 | DEFA14A | DEFA14A | 0001140361-24-018896 | 001-35331 | 24833460 | 34 | 982277 | |||
| 2024-04-09 | DEF 14A | DEF 14A | 0001140361-24-018895 | 001-35331 | 24833433 | 34 | 6872401 | 1 | 1 | |
| 2024-03-28 | PRE 14A | PRE 14A | 0001140361-24-016223 | 001-35331 | 24800164 | 34 | 6886861 | 1 | 1 | |
| 2024-03-26 | 4 | 4 | 0000950170-24-036540 | 4438 | ||||||
| 2024-03-08 | 144 | xsl144X01/primary_doc.xml | 0001974078-24-000107 | 001-35331 | 24734014 | 33 | 4427 | |||
| 2024-03-06 | 4 | 4 | 0000950170-24-027357 | 15519 | ||||||
| 2024-03-06 | 4 | 4 | 0000950170-24-027348 | 14456 | ||||||
| 2024-03-04 | 144 | xsl144X01/primary_doc.xml | 0002007317-24-000272 | 001-35331 | 24716055 | 33 | 5293 | |||
| 2024-03-01 | 4 | 4 | 0000950170-24-024132 | 4793 | ||||||
| 2024-03-01 | 4 | 4 | 0000950170-24-024130 | 4736 | ||||||
| 2024-03-01 | 4 | 4 | 0000950170-24-024126 | 9359 | ||||||
| 2024-03-01 | 4 | 4 | 0000950170-24-024124 | 6439 | ||||||
| 2024-03-01 | 4/A | 4/A | 0000950170-24-024116 | 16359 | ||||||
| 2024-02-28 | 10-K | 10-K | 0000950170-24-022057 | 001-35331 | 24695218 | 34 | 16162478 | 1 | 1 | |
| 2024-02-27 | 8-K | FORM 8-K | 2.02,9.01 | 0001437749-24-005735 | 001-35331 | 24688577 | 34 | 694640 | 1 | 1 |
| 2024-02-14 | SC 13G/A | achc13gadec23.txt | 0001897612-24-001215 | 005-86704 | 34 | 6574 | ||||
| 2024-02-13 | SC 13G/A | SCHEDULE 13G/A | 0001104659-24-020161 | 005-86704 | 24627183 | 34 | 13109 | |||
| 2024-02-09 | SC 13G/A | SEC SCHEDULE 13G | 0000354204-24-002919 | 005-86704 | 24612148 | 34 | 19519 | |||
| 2024-02-09 | SC 13G | filing.txt | 0000315066-24-000958 | 005-86704 | 24611345 | 34 | 8196 | |||
| 2024-02-08 | SC 13G/A | SEC SCHEDULE 13G | 0000902219-24-000037 | 005-86704 | 24607229 | 34 | 37738 | |||
| 2024-01-25 | SC 13G/A | us00404a1097_012524.txt | 0001086364-24-003317 | 005-86704 | 24561082 | 34 | 13747 | |||
| 2024-01-19 | 8-K | 8-K | 1.01,2.03,9.01 | 0001193125-24-011225 | 001-35331 | 24545537 | 34 | 1552848 | 1 | 1 |
| 2023-12-14 | 4 | 4 | 0000950170-23-070551 | 6760 | ||||||
| 2023-11-16 | 4 | 4 | 0000950170-23-064559 | 11493 | ||||||
| 2023-11-15 | 144 | xsl144X01/primary_doc.xml | 0001971857-23-000860 | 001-35331 | 231409741 | 33 | 6552 | |||
| 2023-11-14 | 144 | xsl144X01/primary_doc.xml | 0001971857-23-000855 | 001-35331 | 231407905 | 33 | 5946 | |||
| 2023-11-13 | 4 | 4 | 0000950170-23-063176 | 7358 | ||||||
| 2023-11-13 | 4 | 4 | 0000950170-23-063169 | 5704 | ||||||
| 2023-11-13 | 4 | 4 | 0000950170-23-063149 | 15631 | ||||||
| 2023-11-13 | 144/A | xsl144X01/primary_doc.xml | 0001971857-23-000837 | 001-35331 | 231399984 | 33 | 5503 | |||
| 2023-11-13 | 144/A | xsl144X01/primary_doc.xml | 0001971857-23-000835 | 001-35331 | 231399770 | 33 | 4897 | |||
| 2023-11-13 | 144 | xsl144X01/primary_doc.xml | 0001971857-23-000822 | 001-35331 | 231396109 | 33 | 5337 | |||
| 2023-11-08 | 144 | xsl144X01/primary_doc.xml | 0001971857-23-000816 | 001-35331 | 231389504 | 33 | 4733 | |||
| 2023-11-03 | 10-Q | 10-Q | 0000950170-23-058814 | 001-35331 | 231376324 | 34 | 11046400 | 1 | 1 | |
| 2023-11-02 | 8-K | ACADIA HEALTHCARE COMPANY, INC. 8-K | 2.02,9.01 | 0001157523-23-001637 | 001-35331 | 231373673 | 34 | 780399 | 1 | 1 |
| 2023-10-30 | 8-K | 8-K | 1.01,9.01 | 0001193125-23-266248 | 001-35331 | 231361002 | 34 | 363738 | 1 | 1 |
| 2023-10-27 | 4 | 4 | 0000950170-23-056055 | 4488 | ||||||
| 2023-10-27 | 3 | 3 | 0000950170-23-056050 | 11968 | ||||||
| 2023-10-26 | 8-K | 8-K | 5.02,9.01 | 0001193125-23-264094 | 001-35331 | 231350368 | 34 | 170436 | 1 | 1 |
| 2023-10-11 | 8-K | 8-K | 8.01 | 0001193125-23-254205 | 001-35331 | 231321294 | 34 | 149342 | 1 | 1 |
| 2023-08-15 | 4 | 4 | 0000950170-23-042862 | 13264 | ||||||
| 2023-07-28 | 10-Q | 10-Q | 0000950170-23-035484 | 001-35331 | 231123050 | 34 | 11995950 | 1 | 1 | |
| 2023-07-27 | 4 | 4 | 0000950170-23-035225 | 4598 | ||||||
| 2023-07-27 | 4 | 4 | 0000950170-23-035220 | 4533 | ||||||
| 2023-07-27 | 3 | 3 | 0000950170-23-035215 | 12818 | ||||||
| 2023-07-27 | 8-K | ACADIA HEALTHCARE COMPANY, INC. 8-K | 2.02,9.01 | 0001157523-23-001176 | 001-35331 | 231118515 | 34 | 695757 | 1 | 1 |
| 2023-07-11 | 3 | 3 | 0000950170-23-032532 | 13564 | ||||||
| 2023-07-11 | 8-K | ACADIA HEALTHCARE COMPANY, INC. 8-K | 8.01 | 0001157523-23-001076 | 001-35331 | 231082225 | 34 | 160664 | 1 | 1 |
| 2023-07-05 | 8-K | 8-K | 5.02,9.01 | 0001193125-23-182040 | 001-35331 | 231070567 | 34 | 380104 | 1 | 1 |
| 2023-06-02 | 8-K | 8-K | 5.02,9.01 | 0001193125-23-159929 | 001-35331 | 23989923 | 34 | 341056 | 1 | 1 |
| 2023-05-19 | 4 | FORM 4 SUBMISSION | 0000899243-23-013389 | 4744 | ||||||
| 2023-05-19 | 4 | FORM 4 SUBMISSION | 0000899243-23-013388 | 4707 | ||||||
| 2023-05-19 | 4 | FORM 4 SUBMISSION | 0000899243-23-013385 | 6457 | ||||||
| 2023-05-19 | 4 | FORM 4 SUBMISSION | 0000899243-23-013387 | 4714 | ||||||
| 2023-05-19 | 4 | FORM 4 SUBMISSION | 0000899243-23-013391 | 4686 | ||||||
| 2023-05-19 | 4 | FORM 4 SUBMISSION | 0000899243-23-013390 | 4673 | ||||||
| 2023-05-19 | 4 | FORM 4 SUBMISSION | 0000899243-23-013386 | 4688 | ||||||
| 2023-05-19 | 4 | FORM 4 SUBMISSION | 0000899243-23-013384 | 4692 | ||||||
| 2023-05-19 | 4 | FORM 4 SUBMISSION | 0000899243-23-013383 | 8418 | ||||||
| 2023-05-19 | 8-K | 8-K | 5.02,5.07,9.01 | 0001193125-23-149461 | 001-35331 | 23941274 | 34 | 159913 | 1 | 1 |
| 2023-05-11 | 4 | 4 | 0000950170-23-021424 | 5689 | ||||||
| 2023-05-11 | 4 | 4 | 0000950170-23-021422 | 4542 | ||||||
| 2023-05-11 | 4 | 4 | 0000950170-23-021423 | 4544 | ||||||
| 2023-05-11 | 4 | 4 | 0000950170-23-021421 | 4590 | ||||||
| 2023-05-11 | 4 | 4 | 0000950170-23-021419 | 4548 | ||||||
| 2023-05-04 | 4 | 4 | 0000950170-23-017959 | 4211 | ||||||
| 2023-05-04 | 4 | 4 | 0000950170-23-017957 | 5383 | ||||||
| 2023-04-27 | 10-Q | 10-Q | 0000950170-23-015296 | 001-35331 | 23857265 | 34 | 13052526 | 1 | 1 | |
| 2023-04-26 | 8-K | ACADIA HEALTHCARE COMPANY, INC. 8-K | 2.02,9.01 | 0001157523-23-000620 | 001-35331 | 23849818 | 34 | 522743 | 1 | 1 |
| 2023-04-25 | 4 | FORM 4 SUBMISSION | 0000899243-23-011668 | 4589 | ||||||
| 2023-04-25 | 4 | FORM 4 SUBMISSION | 0000899243-23-011666 | 4605 | ||||||
| 2023-04-25 | 4 | FORM 4 SUBMISSION | 0000899243-23-011665 | 4598 | ||||||
| 2023-04-25 | 4 | 4 | 0000950170-23-014516 | 5519 | ||||||
| 2023-04-13 | 4 | 4 | 0000950170-23-012739 | 4341 | ||||||
| 2023-04-13 | 4 | 4 | 0000950170-23-012738 | 4332 | ||||||
| 2023-04-13 | 4 | 4 | 0000950170-23-012736 | 4348 | ||||||
| 2023-04-07 | ARS | ARS | 0001140361-23-017326 | 001-35331 | 23808802 | 34 | 1608981 | |||
| 2023-04-07 | DEFA14A | DEFA14A | 0001140361-23-017324 | 001-35331 | 23808796 | 34 | 671375 | |||
| 2023-04-07 | DEF 14A | DEF 14A | 0001140361-23-017321 | 001-35331 | 23808781 | 34 | 5867818 | 1 | 1 | |
| 2023-03-27 | 4 | FORM 4 SUBMISSION | 0000899243-23-009735 | 4590 | ||||||
| 2023-03-27 | 4 | FORM 4 SUBMISSION | 0000899243-23-009734 | 4599 | ||||||
| 2023-03-27 | 4 | FORM 4 SUBMISSION | 0000899243-23-009733 | 4606 | ||||||
| 2023-03-27 | 4 | FORM 4 SUBMISSION | 0000899243-23-009732 | 5749 | ||||||
| 2023-03-09 | 4 | FORM 4 SUBMISSION | 0000899243-23-007761 | 4567 | ||||||
| 2023-02-28 | 10-K | 10-K | 0001564590-23-002737 | 001-35331 | 23685463 | 34 | 19670981 | 1 | 1 | |
| 2023-02-27 | 8-K | ACADIA HEALTHCARE COMPANY, INC. 8-K | 2.02,9.01 | 0001157523-23-000366 | 001-35331 | 23674904 | 34 | 797087 | 1 | 1 |
| 2023-02-23 | 4 | FORM 4 SUBMISSION | 0000899243-23-006023 | 6200 | ||||||
| 2023-02-23 | 4 | FORM 4 SUBMISSION | 0000899243-23-006018 | 4873 | ||||||
| 2023-02-23 | 4 | FORM 4 SUBMISSION | 0000899243-23-006017 | 9252 | ||||||
| 2023-02-23 | 4 | FORM 4 SUBMISSION | 0000899243-23-006016 | 8114 | ||||||
| 2023-02-23 | 4 | FORM 4 SUBMISSION | 0000899243-23-006015 | 8098 | ||||||
| 2023-02-23 | 4 | FORM 4 SUBMISSION | 0000899243-23-006011 | 8107 | ||||||
| 2023-02-14 | 5 | FORM 5 SUBMISSION | 0000899243-23-004998 | 7073 | ||||||
| 2023-02-14 | SC 13G/A | achc13gadec22.txt | 0001897612-23-000706 | 005-86704 | 34 | 9842 | ||||
| 2023-02-10 | SC 13G/A | SEC SCHEDULE 13G | 0000354204-23-001336 | 005-86704 | 23610709 | 34 | 19413 | |||
| 2023-02-09 | SC 13G/A | SCHEDULE 13G/A | 0001104659-23-015188 | 005-86704 | 23602143 | 34 | 13007 | |||
| 2023-02-06 | SC 13G/A | SEC SCHEDULE 13G | 0000846087-23-000064 | 005-86704 | 23590021 | 34 | 37347 | |||
| 2023-01-25 | SC 13G | us00404a1097_012523.txt | 0001306550-23-003499 | 005-86704 | 23550532 | 34 | 13458 | |||
| 2022-12-07 | 8-K | ACADIA HEALTHCARE COMPANY, INC. 8-K | 7.01,9.01 | 0001157523-22-001710 | 001-35331 | 221449188 | 34 | 177975 | 1 | 1 |
| 2022-11-02 | 10-Q | 10-Q | 0001564590-22-036269 | 001-35331 | 221353292 | 34 | 12711240 | 1 | 1 | |
| 2022-11-01 | 8-K/A | ACADIA HEALTHCARE COMPANY, INC. 8-K/A | 2.02,7.01,9.01 | 0001157523-22-001454 | 001-35331 | 221348495 | 34 | 854347 | 1 | 1 |
| 2022-10-31 | 8-K | ACADIA HEALTHCARE COMPANY, INC. 8-K | 2.02,9.01 | 0001157523-22-001443 | 001-35331 | 221346728 | 34 | 850630 | 1 | 1 |
| 2022-09-09 | 4 | FORM 4 SUBMISSION | 0000899243-22-030739 | 5063 | ||||||
| 2022-08-16 | 4 | FORM 4 SUBMISSION | 0000899243-22-028819 | 4567 | ||||||
| 2022-08-16 | 4 | FORM 4 SUBMISSION | 0000899243-22-028818 | 4558 | ||||||
| 2022-08-10 | SC 13G | achc13gjul22.txt | 0001897612-22-000263 | 005-86704 | 34 | 9550 | ||||
| 2022-08-10 | SC 13G/A | achc13gajul22.txt | 0000080255-22-002496 | 005-86704 | 34 | 9706 | ||||
| 2022-08-08 | 4 | FORM 4 SUBMISSION | 0000899243-22-028021 | 5122 | ||||||
| 2022-08-08 | 4 | FORM 4 SUBMISSION | 0000899243-22-028020 | 6653 | ||||||
| 2022-08-08 | 4 | FORM 4 SUBMISSION | 0000899243-22-028018 | 12099 | ||||||
| 2022-08-02 | 4 | FORM 4 SUBMISSION | 0000899243-22-027403 | 5055 | ||||||
| 2022-07-28 | 10-Q | 10-Q | 0001564590-22-026910 | 001-35331 | 221115857 | 34 | 12613345 | 1 | 1 | |
| 2022-07-27 | 8-K | ACADIA HEALTHCARE COMPANY, INC. 8-K | 2.02,9.01 | 0001157523-22-000932 | 001-35331 | 221111633 | 34 | 806759 | 1 | 1 |
| 2022-07-22 | 4 | FORM 4 SUBMISSION | 0000899243-22-026588 | 4710 | ||||||
| 2022-07-11 | 3 | FORM 3 SUBMISSION | 0000899243-22-025930 | 7248 | ||||||
| 2022-06-29 | 8-K | 8-K | 5.02,9.01 | 0001193125-22-185179 | 001-35331 | 221055568 | 34 | 166172 | 1 | 1 |
| 2022-05-20 | 4 | FORM 4 SUBMISSION | 0000899243-22-019079 | 4660 | ||||||
| 2022-05-20 | 4 | FORM 4 SUBMISSION | 0000899243-22-019076 | 4675 | ||||||
| 2022-05-20 | 4 | FORM 4 SUBMISSION | 0000899243-22-019073 | 4712 | ||||||
| 2022-05-20 | 4 | FORM 4 SUBMISSION | 0000899243-22-019074 | 4654 | ||||||
| 2022-05-20 | 4 | FORM 4 SUBMISSION | 0000899243-22-019072 | 4656 | ||||||
| 2022-05-20 | 4 | FORM 4 SUBMISSION | 0000899243-22-019071 | 4641 | ||||||
| 2022-05-20 | 4 | FORM 4 SUBMISSION | 0000899243-22-019065 | 6587 | ||||||
| 2022-05-20 | 4 | FORM 4 SUBMISSION | 0000899243-22-019064 | 4682 | ||||||
| 2022-05-20 | 4 | FORM 4 SUBMISSION | 0000899243-22-019063 | 4674 | ||||||
| 2022-05-20 | 8-K | 8-K | 5.07 | 0001193125-22-155213 | 001-35331 | 22944669 | 34 | 155094 | 1 | 1 |
| 2022-05-18 | DEFA14A | DEFA14A | 0001140361-22-019759 | 001-35331 | 22938561 | 34 | 55678 | |||
| 2022-05-12 | DEFA14A | DEFA14A | 0001140361-22-018709 | 001-35331 | 22915354 | 34 | 95980 | |||
| 2022-05-04 | 4 | FORM 4 SUBMISSION | 0000899243-22-016665 | 4573 | ||||||
| 2022-05-04 | 10-Q | 10-Q | 0001564590-22-017872 | 001-35331 | 22891948 | 34 | 11445493 | 1 | 1 | |
| 2022-05-03 | 8-K | ACADIA HEALTHCARE COMPANY, INC. 8-K | 2.02,9.01 | 0001157523-22-000544 | 001-35331 | 22886955 | 34 | 576692 | 1 | 1 |
| 2022-04-26 | 4 | FORM 4 SUBMISSION | 0000899243-22-015689 | 4565 | ||||||
| 2022-04-26 | 4 | FORM 4 SUBMISSION | 0000899243-22-015688 | 4573 | ||||||
| 2022-04-26 | 4 | FORM 4 SUBMISSION | 0000899243-22-015687 | 4556 | ||||||
| 2022-04-13 | 4 | FORM 4 SUBMISSION | 0000899243-22-014749 | 4733 | ||||||
| 2022-04-13 | 4 | FORM 4 SUBMISSION | 0000899243-22-014748 | 5952 | ||||||
| 2022-04-13 | 4 | FORM 4 SUBMISSION | 0000899243-22-014747 | 4742 | ||||||
| 2022-04-13 | 4 | FORM 4 SUBMISSION | 0000899243-22-014746 | 4773 | ||||||
| 2022-04-13 | 4 | FORM 4 SUBMISSION | 0000899243-22-014745 | 4750 | ||||||
| 2022-04-13 | 3 | FORM 3 SUBMISSION | 0000899243-22-014744 | 6756 | ||||||
| 2022-04-08 | DEFA14A | DEFA14A | 0001140361-22-013669 | 001-35331 | 22815310 | 34 | 3763568 | |||
| 2022-04-08 | DEF 14A | DEF 14A | 0001140361-22-013667 | 001-35331 | 22815306 | 34 | 3323532 | |||
| 2022-04-04 | 8-K | ACADIA HEALTHCARE COMPANY, INC. 8-K | 5.02,9.01 | 0001157523-22-000389 | 001-35331 | 22803473 | 34 | 186535 | 1 | 1 |
| 2022-03-25 | 4 | FORM 4 SUBMISSION | 0000899243-22-012369 | 4574 | ||||||
| 2022-03-25 | 4 | FORM 4 SUBMISSION | 0000899243-22-012368 | 4566 | ||||||
| 2022-03-25 | 4 | FORM 4 SUBMISSION | 0000899243-22-012367 | 8521 | ||||||
| 2022-03-25 | 4 | FORM 4 SUBMISSION | 0000899243-22-012366 | 4557 | ||||||
| 2022-03-09 | 4 | FORM 4 SUBMISSION | 0000899243-22-010204 | 4566 | ||||||
| 2022-03-04 | 4 | FORM 4 SUBMISSION | 0000899243-22-009414 | 4573 | ||||||
| 2022-03-04 | 4 | FORM 4 SUBMISSION | 0000899243-22-009413 | 5780 | ||||||
| 2022-03-01 | 4 | FORM 4 SUBMISSION | 0000899243-22-008408 | 7969 | ||||||
| 2022-03-01 | 4 | FORM 4 SUBMISSION | 0000899243-22-008407 | 6283 | ||||||
| 2022-03-01 | 4 | FORM 4 SUBMISSION | 0000899243-22-008402 | 7485 | ||||||
| 2022-03-01 | 4 | FORM 4 SUBMISSION | 0000899243-22-008404 | 6270 | ||||||
| 2022-03-01 | 4 | FORM 4 SUBMISSION | 0000899243-22-008401 | 6279 | ||||||
| 2022-03-01 | 10-K | 10-K | 0001564590-22-007930 | 001-35331 | 22695923 | 34 | 20711919 | 1 | 1 | |
| 2022-02-28 | 8-K | ACADIA HEALTHCARE COMPANY, INC. 8-K | 2.02,9.01 | 0001157523-22-000270 | 001-35331 | 22689792 | 34 | 1123280 | 1 | 1 |
| 2022-02-14 | SC 13G/A | achc13gadec21.txt | 0000080255-22-002080 | 005-86704 | 34 | 9526 | ||||
| 2022-02-09 | SC 13G/A | SCHEDULE 13G/A | 0001104659-22-016357 | 005-86704 | 22606232 | 34 | 13002 | |||
| 2022-02-08 | SC 13G/A | SEC SCHEDULE 13G | 0000354204-22-001486 | 005-86704 | 22601012 | 34 | 19413 | |||
| 2022-02-04 | SC 13G/A | SEC SCHEDULE 13G | 0001678858-22-000097 | 005-86704 | 22591238 | 34 | 37366 | |||
| 2022-02-03 | SC 13G/A | us00404a1097_020322.txt | 0000834237-22-006433 | 005-86704 | 22589181 | 34 | 13466 | |||
| 2022-02-02 | 4 | FORM 4 SUBMISSION | 0000899243-22-004208 | 4552 | ||||||
| 2022-02-01 | 8-K | 8-K | 5.02,9.01 | 0001193125-22-024575 | 001-35331 | 22578938 | 34 | 176376 | 1 | 1 |
| 2021-10-29 | 10-Q | 10-Q | 0001564590-21-052945 | 001-35331 | 211363301 | 34 | 14256819 | 1 | 1 | |
| 2021-10-28 | 8-K | ACADIA HEALTHCARE COMPANY, INC. 8-K | 2.02,9.01 | 0001157523-21-001282 | 001-35331 | 211358788 | 34 | 953789 | 1 | 1 |
| 2021-10-05 | 8-K | ACADIA HEALTHCARE COMPANY, INC. 8-K | 5.02,9.01 | 0001157523-21-001181 | 001-35331 | 211305219 | 34 | 172921 | 1 | 1 |
| 2021-08-16 | 4 | FORM 4 SUBMISSION | 0000899243-21-033124 | 4567 | ||||||
| 2021-08-03 | S-8 | S-8 | 0001193125-21-235080 | 333-258420 | 211140790 | 33 | 79400 | |||
| 2021-08-03 | 10-Q | 10-Q | 0001564590-21-040250 | 001-35331 | 211139994 | 34 | 13943448 | 1 | 1 | |
| 2021-08-02 | 8-K | ACADIA HEALTHCARE COMPANY, INC. 8-K | 2.02,9.01 | 0001157523-21-000964 | 001-35331 | 211136177 | 34 | 897021 | 1 | 1 |
| 2021-06-16 | 4 | FORM 4 SUBMISSION | 0000899243-21-024164 | 9665 | ||||||
| 2021-06-16 | 4 | FORM 4 SUBMISSION | 0000899243-21-024163 | 4567 | ||||||
| 2021-05-07 | 4 | FORM 4 SUBMISSION | 0000899243-21-018714 | 4681 | ||||||
| 2021-05-07 | 4 | FORM 4 SUBMISSION | 0000899243-21-018715 | 4673 | ||||||
| 2021-05-07 | 4 | FORM 4 SUBMISSION | 0000899243-21-018712 | 4711 | ||||||
| 2021-05-07 | 4 | FORM 4 SUBMISSION | 0000899243-21-018713 | 4674 | ||||||
| 2021-05-07 | 4 | FORM 4 SUBMISSION | 0000899243-21-018710 | 4640 | ||||||
| 2021-05-07 | 4 | FORM 4 SUBMISSION | 0000899243-21-018708 | 6647 | ||||||
| 2021-05-07 | 4 | FORM 4 SUBMISSION | 0000899243-21-018709 | 4652 | ||||||
| 2021-05-07 | 4 | FORM 4 SUBMISSION | 0000899243-21-018711 | 4655 | ||||||
| 2021-05-07 | 8-K | 8-K | 5.02,5.07,9.01 | 0001193125-21-155064 | 001-35331 | 21903761 | 34 | 166158 | 1 | 1 |
| 2021-05-04 | 4 | FORM 4 SUBMISSION | 0000899243-21-018153 | 4572 | ||||||
| 2021-05-04 | 4 | FORM 4 SUBMISSION | 0000899243-21-018152 | 5780 | ||||||
| 2021-04-30 | 10-Q | 10-Q | 0001564590-21-022545 | 001-35331 | 21878316 | 34 | 12388079 | 1 | 1 | |
| 2021-04-29 | 8-K | ACADIA HEALTHCARE COMPANY, INC. 8-K | 2.02,9.01 | 0001157523-21-000547 | 001-35331 | 21870649 | 34 | 682808 | 1 | 1 |
| 2021-04-27 | 4 | FORM 4 SUBMISSION | 0000899243-21-017119 | 4733 | ||||||
| 2021-04-27 | 4 | FORM 4 SUBMISSION | 0000899243-21-017118 | 4749 | ||||||
| 2021-04-27 | 4 | FORM 4 SUBMISSION | 0000899243-21-017117 | 4742 | ||||||
| 2021-04-27 | 4 | FORM 4 SUBMISSION | 0000899243-21-017116 | 5952 | ||||||
| 2021-03-26 | 4 | FORM 4 SUBMISSION | 0000899243-21-013702 | 4566 | ||||||
| 2021-03-24 | DEFA14A | DEFA14A | 0001193125-21-092745 | 001-35331 | 21768923 | 34 | 222870 | |||
| 2021-03-24 | DEF 14A | DEF 14A | 0001193125-21-092741 | 001-35331 | 21768903 | 34 | 1037378 | |||
| 2021-03-22 | 8-K | 8-K | 1.01,1.02,2.03,9.01 | 0001193125-21-088596 | 001-35331 | 21760022 | 34 | 1609718 | 1 | 1 |
| 2021-03-16 | 4 | FORM 4 SUBMISSION | 0000899243-21-011976 | 6063 | ||||||
| 2021-03-15 | 4 | FORM 4 SUBMISSION | 0000899243-21-011682 | 7248 | ||||||
| 2021-03-15 | 4 | FORM 4 SUBMISSION | 0000899243-21-011603 | 19887 | ||||||
| 2021-03-15 | 4 | FORM 4 SUBMISSION | 0000899243-21-011600 | 16478 | ||||||
| 2021-03-09 | 4 | FORM 4 SUBMISSION | 0000899243-21-010695 | 4566 | ||||||
| 2021-03-02 | 4 | FORM 4 SUBMISSION | 0000899243-21-009020 | 9011 | ||||||
| 2021-03-02 | 4 | FORM 4 SUBMISSION | 0000899243-21-009010 | 7805 | ||||||
| 2021-02-26 | 10-K | 10-K | 0001564590-21-009466 | 001-35331 | 21689625 | 34 | 22586002 | 1 | 1 | |
| 2021-02-26 | 8-K | ACADIA HEALTHCARE COMPANY, INC. 8-K | 2.02,9.01 | 0001157523-21-000271 | 001-35331 | 21682067 | 34 | 1125141 | 1 | 1 |
| 2021-02-16 | SC 13G/A | achc13gadec20.txt | 0000080255-21-001187 | 005-86704 | 34 | 9526 | ||||
| 2021-02-12 | SC 13G/A | SEC SCHEDULE 13G | 0000354204-21-000091 | 005-86704 | 21625949 | 34 | 19422 | |||
| 2021-02-10 | SC 13G/A | SCHEDULE 13G/A | 0001104659-21-017326 | 005-86704 | 21609956 | 34 | 13872 | |||
| 2021-02-03 | SC 13G/A | SEC SCHEDULE 13G | 0000902219-21-000055 | 005-86704 | 21585426 | 34 | 37631 | |||
| 2021-01-29 | SC 13G/A | us00404a1097_012821.txt | 0000834237-21-002818 | 005-86704 | 21566794 | 34 | 13447 | |||
| 2021-01-22 | 8-K | 8-K | 5.02,9.01 | 0001193125-21-013858 | 001-35331 | 21543513 | 34 | 305518 | 1 | 1 |
| 2021-01-21 | 8-K | 8-K | 2.01,9.01 | 0001193125-21-013526 | 001-35331 | 21542382 | 34 | 354019 | 1 | 1 |
| 2021-01-07 | 8-K | 8-K | 1.01 | 0001193125-21-004146 | 001-35331 | 21514233 | 34 | 151276 | 1 | 1 |
| 2020-12-30 | 8-K | 8-K | 1.01,7.01,9.01 | 0001193125-20-329213 | 001-35331 | 201424193 | 34 | 183559 | 1 | 1 |
| 2020-12-16 | 4 | FORM 4 SUBMISSION | 0000899243-20-034127 | 6765 | ||||||
| 2020-12-11 | SC 13D/A | SC 13D/A | 0001104659-20-134817 | 005-86704 | 201384381 | 34 | 111336 | |||
| 2020-11-13 | 8-K | 8-K | 1.01,2.03,9.01 | 0001193125-20-293046 | 001-35331 | 201311920 | 34 | 471804 | 1 | 1 |
| 2020-11-09 | SC 13G/A | FILING ACADIA HEALTHCARE COMPANY, INC. | 0000019617-20-000461 | 005-86704 | 34 | 89794 | ||||
| 2020-10-30 | 4 | FORM 4 SUBMISSION | 0000899243-20-029941 | 4658 | ||||||
| 2020-10-30 | 3 | FORM 3 SUBMISSION | 0000899243-20-029939 | 6544 | ||||||
| 2020-10-30 | 10-Q | 10-Q | 0001564590-20-049309 | 001-35331 | 201277458 | 34 | 16302206 | 1 | 1 | |
| 2020-10-29 | 8-K | ACADIA HEALTHCARE COMPANY, INC. 8-K | 2.02,9.01 | 0001157523-20-001384 | 001-35331 | 201272843 | 34 | 838559 | 1 | 1 |
| 2020-10-28 | 8-K | 8-K | 5.02,9.01 | 0001193125-20-279955 | 001-35331 | 201269416 | 34 | 164200 | 1 | 1 |
| 2020-10-21 | UPLOAD | filename1.pdf | 0000000000-20-009955 | 39733 | ||||||
| 2020-10-14 | 8-K | FORM 8-K | 1.01,2.03,9.01 | 0001193125-20-269130 | 001-35331 | 201238524 | 34 | 1296087 | 1 | 1 |
| 2020-10-08 | CORRESP | filename1.htm | 0001564590-20-046111 | 34531 | ||||||
| 2020-09-29 | 8-K | 8-K | 8.01,9.01 | 0001193125-20-257992 | 001-35331 | 201209777 | 34 | 213225 | 1 | 1 |
| 2020-09-25 | UPLOAD | filename1.pdf | 0000000000-20-009079 | 46581 | ||||||
| 2020-08-05 | 10-Q | ACHC-10-Q-20200630 | 0001564590-20-036834 | 001-35331 | 201077614 | 34 | 15737646 | 1 | 1 | |
| 2020-08-04 | 8-K | ACADIA HEALTHCARE COMPANY, INC. 8-K | 2.02,9.01 | 0001157523-20-001120 | 001-35331 | 201073692 | 34 | 841567 | 1 | 1 |
| 2020-06-24 | 8-K | 8-K | 1.01,1.02,2.03,9.01 | 0001193125-20-177619 | 001-35331 | 20985493 | 34 | 1285390 | 1 | 1 |
| 2020-06-12 | 4 | FORM 4 SUBMISSION | 0000899243-20-016428 | 9723 | ||||||
| 2020-06-10 | 8-K | 8-K | 8.01,9.01 | 0001193125-20-165755 | 001-35331 | 20955213 | 34 | 201404 | 1 | 1 |
| 2020-05-13 | 4 | FORM 4 SUBMISSION | 0000899243-20-012994 | 6788 | ||||||
| 2020-05-08 | 4 | FORM 4 SUBMISSION | 0000899243-20-012430 | 4674 | ||||||
| 2020-05-08 | 4 | FORM 4 SUBMISSION | 0000899243-20-012429 | 4742 | ||||||
| 2020-05-08 | 4 | FORM 4 SUBMISSION | 0000899243-20-012428 | 4640 | ||||||
| 2020-05-08 | 4 | FORM 4 SUBMISSION | 0000899243-20-012427 | 4712 | ||||||
| 2020-05-08 | 4 | FORM 4 SUBMISSION | 0000899243-20-012426 | 4704 | ||||||
| 2020-05-08 | 4 | FORM 4 SUBMISSION | 0000899243-20-012425 | 4686 | ||||||
| 2020-05-08 | 8-K | 8-K | 5.07 | 0001193125-20-137676 | 001-35331 | 20861507 | 34 | 158562 | 1 | 1 |
| 2020-05-05 | 10-Q | 10-Q | 0001564590-20-021269 | 001-35331 | 20849100 | 34 | 21178214 | 1 | 1 | |
| 2020-05-04 | 8-K | ACADIA HEALTHCARE COMPANY, INC. 8-K | 2.02,9.01 | 0001157523-20-000644 | 001-35331 | 20845045 | 34 | 532543 | 1 | 1 |
One latest value per concept from companyfacts (532 concepts). Full history stays in the JSON.
| Taxonomy | Tag | Label | Unit | Value | Start | End | FY | FP | Form | Filed | Accn |
|---|---|---|---|---|---|---|---|---|---|---|---|
| dei | EntityCommonStockSharesOutstanding | Entity Common Stock, Shares Outstanding | shares | 92.97M | 2026-11-03 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447412 | |
| dei | EntityPublicFloat | Entity Public Float | USD | 2.10B | 2025-06-30 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-078266 | |
| ffd | NetFeeAmt | NetFeeAmt | USD | 10,297.43 | 2026-05-11 | S-8 | 2026-05-11 | 0001193125-26-217120 | |||
| ffd | TtlFeeAmt | TtlFeeAmt | USD | 10,297.43 | 2026-05-11 | S-8 | 2026-05-11 | 0001193125-26-217120 | |||
| ffd | TtlOfferingAmt | TtlOfferingAmt | USD | 74.56M | 2026-05-11 | S-8 | 2026-05-11 | 0001193125-26-217120 | |||
| ffd | TtlOffsetAmt | TtlOffsetAmt | USD | 0 | 2026-05-11 | S-8 | 2026-05-11 | 0001193125-26-217120 | |||
| us-gaap | AccountsPayableCurrent | Accounts Payable, Current | USD | 138.56M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447412 | |
| us-gaap | AccountsReceivableNetCurrent | Accounts Receivable, after Allowance for Credit Loss, Current | USD | 501.38M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447412 | |
| us-gaap | AccrualForTaxesOtherThanIncomeTaxesCurrent | Accrual for Taxes Other than Income Taxes, Current | USD | 16.79M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447412 | |
| us-gaap | AccruedInsuranceCurrent | Accrued Insurance, Current | USD | 50.34M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447412 | |
| us-gaap | AccruedLiabilitiesCurrent | Accrued Liabilities, Current | USD | 37.27M | 2017-12-31 | 2017 | FY | 10-K | 2018-02-27 | 0001193125-18-061152 | |
| us-gaap | AccumulatedAmortizationDeferredFinanceCosts | Accumulated Amortization, Debt Issuance Costs | USD | 11.60M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-078266 | |
| us-gaap | AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment | Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment | USD | 1.14B | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447412 | |
| us-gaap | AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax | Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax | USD | -5.20M | 2019-12-31 | 2019 | FY | 10-K | 2020-02-28 | 0001564590-20-007769 | |
| us-gaap | AccumulatedOtherComprehensiveIncomeLossNetOfTax | Accumulated Other Comprehensive Income (Loss), Net of Tax | USD | -371.37M | 2020-12-31 | 2021 | FY | 10-K | 2022-03-01 | 0001564590-22-007930 | |
| us-gaap | AdditionalPaidInCapital | Additional Paid in Capital | USD | 847.30M | 2014-12-31 | 2014 | FY | 10-K | 2015-02-27 | 0001193125-15-069793 | |
| us-gaap | AdditionalPaidInCapitalCommonStock | Additional Paid in Capital, Common Stock | USD | 2.74B | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447412 | |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalOther | Adjustments to Additional Paid in Capital, Other | USD | -19,000 | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447412 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue | APIC, Share-based Payment Arrangement, Increase for Cost Recognition | USD | 9.25M | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447412 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs | USD | -897,000 | 2011-01-01 | 2011-12-31 | 2011 | FY | 8-K | 2012-10-17 | 0001193125-12-425224 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation | Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation | USD | 309,000 | 2015-01-01 | 2015-12-31 | 2017 | FY | 10-K | 2018-02-27 | 0001193125-18-061152 |
| us-gaap | AllocatedShareBasedCompensationExpense | Share-based Payment Arrangement, Expense | USD | 2.27M | 2012-01-01 | 2012-12-31 | 2012 | FY | 10-K | 2013-03-01 | 0001193125-13-087740 |
| us-gaap | AllowanceForDoubtfulAccountsReceivable | Accounts Receivable, Allowance for Credit Loss | USD | 39.80M | 2017-12-31 | 2017 | FY | 10-K | 2018-02-27 | 0001193125-18-061152 | |
| us-gaap | AllowanceForDoubtfulAccountsReceivableChargeOffs | Allowance for Doubtful Accounts Receivable, Charge-offs (Deprecated 2013-01-31) | USD | 1.33M | 2012-01-01 | 2012-12-31 | 2012 | FY | 10-K | 2013-03-01 | 0001193125-13-087740 |
| us-gaap | AllowanceForDoubtfulAccountsReceivableCurrent | Accounts Receivable, Allowance for Credit Loss, Current | USD | 39.80M | 2017-12-31 | 2017 | FY | 10-K | 2018-02-27 | 0001193125-18-061152 | |
| us-gaap | AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease | Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease) | USD | 40.92M | 2017-01-01 | 2017-12-31 | 2017 | FY | 10-K | 2018-02-27 | 0001193125-18-061152 |
| us-gaap | AllowanceForDoubtfulAccountsReceivableWriteOffs | Accounts Receivable, Allowance for Credit Loss, Writeoff | USD | 40.03M | 2017-01-01 | 2017-12-31 | 2017 | FY | 10-K | 2018-02-27 | 0001193125-18-061152 |
| us-gaap | AmortizationOfFinancingCosts | Amortization of Debt Issuance Costs | USD | 3.80M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447412 |
| us-gaap | AmortizationOfIntangibleAssets | Amortization of Intangible Assets | USD | 400,000 | 2016-01-01 | 2016-12-31 | 2017 | FY | 10-K | 2018-02-27 | 0001193125-18-061152 |
| us-gaap | AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | shares | 1.00M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-078266 |
| us-gaap | AssetImpairmentCharges | Asset Impairment Charges | USD | 10.91M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447412 |
| us-gaap | Assets | Assets | USD | 5.55B | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447412 | |
| us-gaap | AssetsCurrent | Assets, Current | USD | 881.32M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447412 | |
| us-gaap | AssetsHeldForSaleNotPartOfDisposalGroup | Assets Held-for-sale, Not Part of Disposal Group | USD | 31.10M | 2019-12-31 | 2019 | FY | 10-K | 2020-02-28 | 0001564590-20-007769 | |
| us-gaap | AssetsHeldForSaleNotPartOfDisposalGroupCurrent | Assets Held-for-sale, Not Part of Disposal Group, Current | USD | 71.20M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447412 | |
| us-gaap | AssetsHeldForSaleNotPartOfDisposalGroupCurrentOther | Assets Held-for-sale, Not Part of Disposal Group, Current, Other | USD | 15.81M | 2021-12-31 | 2021 | FY | 10-K | 2022-03-01 | 0001564590-22-007930 | |
| us-gaap | AssetsOfDisposalGroupIncludingDiscontinuedOperation | Disposal Group, Including Discontinued Operation, Assets | USD | 392.48M | 2016-09-30 | 2016 | Q3 | 10-Q | 2016-11-02 | 0001193125-16-757061 | |
| us-gaap | AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent | Disposal Group, Including Discontinued Operation, Assets, Current | USD | 1.81B | 2020-12-31 | 2021 | FY | 10-K | 2022-03-01 | 0001564590-22-007930 | |
| us-gaap | BuildingsAndImprovementsGross | Buildings and Improvements, Gross | USD | 2.42B | 2018-12-31 | 2018 | FY | 10-K | 2019-03-01 | 0001564590-19-005750 | |
| us-gaap | BusinessAcquisitionContingentConsiderationAtFairValue | Business Acquisition, Contingent Consideration, at Fair Value (Deprecated 2013-01-31) | USD | 6.12M | 2013-03-31 | 2013 | Q1 | 10-Q | 2013-05-02 | 0001193125-13-196184 | |
| us-gaap | BusinessAcquisitionPurchasePriceAllocationAssetsAcquired | Business Acquisition, Purchase Price Allocation, Assets Acquired (Deprecated 2013-01-31) | USD | 484.54M | 2012-12-31 | 2012 | FY | 10-K | 2013-03-01 | 0001193125-13-087740 | |
| us-gaap | BusinessAcquisitionPurchasePriceAllocationAssetsAcquiredLiabilitiesAssumedNet | Business Acquisition, Purchase Price Allocation, Assets Acquired (Liabilities Assumed), Net (Deprecated 2013-01-31) | USD | 439.56M | 2012-12-31 | 2012 | FY | 10-K | 2013-03-01 | 0001193125-13-087740 | |
| us-gaap | BusinessAcquisitionPurchasePriceAllocationCurrentAssetsCashAndCashEquivalents | Business Acquisition, Purchase Price Allocation, Current Assets, Cash and Cash Equivalents (Deprecated 2013-01-31) | USD | 1.65M | 2012-12-31 | 2012 | FY | 10-K | 2013-03-01 | 0001193125-13-087740 | |
| us-gaap | BusinessAcquisitionPurchasePriceAllocationCurrentAssetsPrepaidExpenseAndOtherAssets | Business Acquisition, Purchase Price Allocation, Current Assets, Prepaid Expense and Other Assets (Deprecated 2013-01-31) | USD | 4.95M | 2012-12-31 | 2012 | FY | 10-K | 2013-03-01 | 0001193125-13-087740 | |
| us-gaap | BusinessAcquisitionPurchasePriceAllocationCurrentAssetsReceivables | Business Acquisition, Purchase Price Allocation, Current Assets, Receivables (Deprecated 2013-01-31) | USD | 19.50M | 2012-12-31 | 2012 | FY | 10-K | 2013-03-01 | 0001193125-13-087740 | |
| us-gaap | BusinessAcquisitionPurchasePriceAllocationCurrentLiabilitiesAccountsPayable | Business Acquisition, Purchase Price Allocation, Current Liabilities, Accounts Payable (Deprecated 2013-01-31) | USD | 7.40M | 2012-12-31 | 2012 | FY | 10-K | 2013-03-01 | 0001193125-13-087740 | |
| us-gaap | BusinessAcquisitionPurchasePriceAllocationCurrentLiabilitiesAccruedLiabilities | Business Acquisition, Purchase Price Allocation, Current Liabilities, Accrued Liabilities (Deprecated 2013-01-31) | USD | 7.17M | 2012-12-31 | 2012 | FY | 10-K | 2013-03-01 | 0001193125-13-087740 | |
| us-gaap | BusinessAcquisitionPurchasePriceAllocationCurrentLiabilitiesOtherLiabilities | Business Acquisition, Purchase Price Allocation, Current Liabilities, Other Liabilities (Deprecated 2013-01-31) | USD | 3.12M | 2012-12-31 | 2012 | FY | 10-K | 2013-03-01 | 0001193125-13-087740 | |
| us-gaap | BusinessAcquisitionPurchasePriceAllocationDeferredTaxLiabilitiesNoncurrent | Business Acquisition, Purchase Price Allocation, Deferred Tax Liabilities, Noncurrent (Deprecated 2013-01-31) | USD | 419,000 | 2011-12-31 | 2012 | FY | 10-K | 2013-03-01 | 0001193125-13-087740 | |
| us-gaap | BusinessAcquisitionPurchasePriceAllocationGoodwillAmount | Business Acquisition, Purchase Price Allocation, Goodwill Amount (Deprecated 2013-01-31) | USD | 369.55M | 2012-12-31 | 2012 | FY | 10-K | 2013-03-01 | 0001193125-13-087740 | |
| us-gaap | BusinessAcquisitionPurchasePriceAllocationIntangibleAssetsOtherThanGoodwill | Business Acquisition, Purchase Price Allocation, Intangible Assets Other than Goodwill (Deprecated 2013-01-31) | USD | 7.98M | 2012-12-31 | 2012 | FY | 10-K | 2013-03-01 | 0001193125-13-087740 | |
| us-gaap | BusinessAcquisitionPurchasePriceAllocationLiabilitiesAssumed | Business Acquisition, Purchase Price Allocation, Liabilities Assumed (Deprecated 2013-01-31) | USD | 44.98M | 2012-12-31 | 2012 | FY | 10-K | 2013-03-01 | 0001193125-13-087740 | |
| us-gaap | BusinessAcquisitionPurchasePriceAllocationNoncurrentLiabilitiesLongTermDebt | Business Acquisition, Purchase Price Allocation, Noncurrent Liabilities, Long-term Debt (Deprecated 2013-01-31) | USD | 25.60M | 2012-12-31 | 2012 | FY | 10-K | 2013-03-01 | 0001193125-13-087740 | |
| us-gaap | BusinessAcquisitionPurchasePriceAllocationOtherAssets | Business Acquisition, Purchase Price Allocation, Other Assets (Deprecated 2013-01-31) | USD | 2.59M | 2012-12-31 | 2012 | FY | 10-K | 2013-03-01 | 0001193125-13-087740 | |
| us-gaap | BusinessAcquisitionPurchasePriceAllocationOtherLiabilities | Business Acquisition, Purchase Price Allocation, Other Liabilities (Deprecated 2013-01-31) | USD | 1.70M | 2012-12-31 | 2012 | FY | 10-K | 2013-03-01 | 0001193125-13-087740 | |
| us-gaap | BusinessAcquisitionPurchasePriceAllocationPropertyPlantAndEquipment | Business Acquisition, Purchase Price Allocation, Property, Plant and Equipment (Deprecated 2013-01-31) | USD | 78.31M | 2012-12-31 | 2012 | FY | 10-K | 2013-03-01 | 0001193125-13-087740 | |
| us-gaap | BusinessAcquisitionsProFormaRevenue | Business Acquisition, Pro Forma Revenue | USD | 2.77B | 2016-01-01 | 2016-12-31 | 2016 | FY | 10-K | 2017-02-24 | 0001193125-17-056016 |
| us-gaap | BusinessCombinationAcquisitionRelatedCosts | Business Combination, Acquisition Related Costs | USD | 68.33M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447412 |
| us-gaap | BusinessCombinationAssetsAndLiabilitiesArisingFromContingenciesAmountRecognized | Business Combination, Assets and Liabilities Arising from Contingencies, Amount Recognized, Net | USD | 667,000 | 2015-12-31 | 2015 | FY | 10-K | 2016-02-26 | 0001193125-16-478707 | |
| us-gaap | BusinessCombinationAssetsAndLiabilitiesArisingFromContingenciesAmountRecognizedOtherThanAtFairValue | Business Combination, Assets and Liabilities Arising from Contingencies, Amount Recognized, Other than at Fair Value, Net | USD | 6.12M | 2013-06-30 | 2013 | Q2 | 10-Q | 2013-07-31 | 0001193125-13-312513 | |
| us-gaap | BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1 | Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability | USD | 500,000 | 2014-01-01 | 2014-09-30 | 2014 | Q3 | 10-Q | 2014-10-30 | 0001193125-14-389873 |
| us-gaap | BusinessCombinationContingentConsiderationLiability | Business Combination, Contingent Consideration, Liability | USD | 3.47M | 2014-09-30 | 2014 | Q3 | 10-Q | 2014-10-30 | 0001193125-14-389873 | |
| us-gaap | BusinessExitCosts1 | Business Exit Costs | USD | 12.84M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447412 |
| us-gaap | CashAndCashEquivalentsAtCarryingValue | Cash and Cash Equivalents, at Carrying Value | USD | 163.31M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447412 | |
| us-gaap | CashAndCashEquivalentsFairValueDisclosure | Cash and Cash Equivalents, Fair Value Disclosure | USD | 120.18M | 2012-06-30 | 2012 | Q2 | 10-Q | 2012-08-02 | 0001193125-12-329266 | |
| us-gaap | CashAndCashEquivalentsPeriodIncreaseDecrease | Cash and Cash Equivalents, Period Increase (Decrease) | USD | -6.97M | 2019-01-01 | 2019-06-30 | 2019 | Q2 | 10-Q | 2019-07-31 | 0001564590-19-027472 |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | USD | 133.81M | 2021-12-31 | 2021 | FY | 10-K | 2022-03-01 | 0001564590-22-007930 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations | USD | 163.31M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447412 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | USD | 30.07M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447412 |
| us-gaap | CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations | Cash Provided by (Used in) Financing Activities, Discontinued Operations | USD | -3.25M | 2020-01-01 | 2020-12-31 | 2022 | FY | 10-K | 2023-02-28 | 0001564590-23-002737 |
| us-gaap | CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations | Cash Provided by (Used in) Investing Activities, Discontinued Operations | USD | -43.60M | 2020-01-01 | 2020-12-31 | 2022 | FY | 10-K | 2023-02-28 | 0001564590-23-002737 |
| us-gaap | CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations | Cash Provided by (Used in) Operating Activities, Discontinued Operations | USD | 253,000 | 2021-01-01 | 2021-12-31 | 2023 | FY | 10-K | 2024-02-28 | 0000950170-24-022057 |
| us-gaap | CharityCareDirectAndIndirectCostBasisAmount | Charity Care, Direct and Indirect Cost Basis, Amount | USD | 12.00M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-078266 |
| us-gaap | ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights | Class of Warrant or Right, Exercise Price of Warrants or Rights (Deprecated 2014-01-31) | USD/Warrant | 14 | 2013-12-31 | 2013 | FY | 10-K | 2014-02-21 | 0001193125-14-062774 | |
| us-gaap | ClassOfWarrantOrRightOutstanding | Class of Warrant or Right, Outstanding | shares | 0 | 2016-12-31 | 2016 | FY | 10-K | 2017-02-24 | 0001193125-17-056016 | |
| us-gaap | CommonStockDiscountOnShares | Common Stock, Discount on Shares | USD | 15.80M | 2016-01-12 | 2017 | FY | 10-K | 2018-02-27 | 0001193125-18-061152 | |
| us-gaap | CommonStockParOrStatedValuePerShare | Common Stock, Par or Stated Value Per Share | USD/shares | 0.01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447412 | |
| us-gaap | CommonStockSharesAuthorized | Common Stock, Shares Authorized | shares | 180.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447412 | |
| us-gaap | CommonStockSharesIssued | Common Stock, Shares, Issued | shares | 90.91M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447412 | |
| us-gaap | CommonStockSharesOutstanding | Common Stock, Shares, Outstanding | shares | 90.91M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447412 | |
| us-gaap | CommonStockValue | Common Stock, Value, Issued | USD | 909,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447412 | |
| us-gaap | ComprehensiveIncomeNetOfTax | Comprehensive Income (Loss), Net of Tax, Attributable to Parent | USD | -21.67M | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-02-28 | 0000950170-24-022057 |
| us-gaap | ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest | Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest | USD | 6.01M | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-02-28 | 0000950170-24-022057 |
| us-gaap | ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest | Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest | USD | -15.66M | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-02-28 | 0000950170-24-022057 |
| us-gaap | ConstructionInProgressGross | Construction in Progress, Gross | USD | 294.85M | 2018-12-31 | 2018 | FY | 10-K | 2019-03-01 | 0001564590-19-005750 | |
| us-gaap | ContractWithCustomerLiabilityCurrent | Contract with Customer, Liability, Current | USD | 2.21M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447412 | |
| us-gaap | ContractWithCustomerLiabilityRevenueRecognized | Contract with Customer, Liability, Revenue Recognized | USD | 65.60M | 2025-04-01 | 2025-06-30 | 2025 | Q2 | 10-Q | 2025-08-05 | 0000950170-25-103160 |
| us-gaap | CostsAndExpenses | Costs and Expenses | USD | 2.50B | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447412 |
| us-gaap | CurrentFederalTaxExpenseBenefit | Current Federal Tax Expense (Benefit) | USD | 19.41M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-078266 |
| us-gaap | CurrentForeignTaxExpenseBenefit | Current Foreign Tax Expense (Benefit) | USD | 416,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-078266 |
| us-gaap | CurrentIncomeTaxExpenseBenefit | Current Income Tax Expense (Benefit) | USD | 24.89M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-078266 |
| us-gaap | CurrentStateAndLocalTaxExpenseBenefit | Current State and Local Tax Expense (Benefit) | USD | 5.06M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-078266 |
| us-gaap | DebtInstrumentCarryingAmount | Long-term Debt, Gross | USD | 2.52B | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-078266 | |
| us-gaap | DebtInstrumentInterestRateStatedPercentage | Debt Instrument, Interest Rate, Stated Percentage | pure | 0.129 | 2012-12-31 | 2012 | FY | 10-K | 2013-03-01 | 0001193125-13-087740 | |
| us-gaap | DebtInstrumentPeriodicPayment | Debt Instrument, Periodic Payment | USD | 20.00M | 2019-11-15 | 2020 | FY | 10-K | 2021-02-26 | 0001564590-21-009466 | |
| us-gaap | DebtIssuanceCosts | Debt Issuance Cost (Deprecated 2016-01-31) | USD | 37.60M | 2015-01-01 | 2015-12-31 | 2015 | FY | 10-K | 2016-02-26 | 0001193125-16-478707 |
| us-gaap | DeferredFederalIncomeTaxExpenseBenefit | Deferred Federal Income Tax Expense (Benefit) | USD | -32.25M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-078266 |
| us-gaap | DeferredFinanceCostsNet | Debt Issuance Costs, Net | USD | 16.80M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-078266 | |
| us-gaap | DeferredForeignIncomeTaxExpenseBenefit | Deferred Foreign Income Tax Expense (Benefit) | USD | 117,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-078266 |
| us-gaap | DeferredIncomeTaxAssetsNet | Deferred Income Tax Assets, Net | USD | 2.42M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447412 | |
| us-gaap | DeferredIncomeTaxesAndTaxCredits | Deferred Income Taxes and Tax Credits | USD | 28.93M | 2015-01-01 | 2015-09-30 | 2015 | Q3 | 10-Q | 2015-11-04 | 0001193125-15-366114 |
| us-gaap | DeferredIncomeTaxExpenseBenefit | Deferred Income Tax Expense (Benefit) | USD | 27.14M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447412 |
| us-gaap | DeferredIncomeTaxLiabilities | Deferred Tax Liabilities, Gross | USD | 215.35M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-078266 | |
| us-gaap | DeferredIncomeTaxLiabilitiesNet | Deferred Income Tax Liabilities, Net | USD | 93.64M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447412 | |
| us-gaap | DeferredRevenueCurrent | Deferred Revenue, Current | USD | 20.25M | 2022-06-30 | 2022 | Q2 | 10-Q | 2022-07-28 | 0001564590-22-026910 | |
| us-gaap | DeferredStateAndLocalIncomeTaxExpenseBenefit | Deferred State and Local Income Tax Expense (Benefit) | USD | 33.23M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-078266 |
| us-gaap | DeferredTaxAssetsCapitalLossCarryforwards | Deferred Tax Assets, Capital Loss Carryforwards | USD | 216.72M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-078266 | |
| us-gaap | DeferredTaxAssetsGross | Deferred Tax Assets, Gross | USD | 420.65M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-078266 | |
| us-gaap | DeferredTaxAssetsGrossCurrent | Deferred Tax Assets, Gross, Current | USD | 0 | 2015-12-31 | 2015 | FY | 10-K | 2016-02-26 | 0001193125-16-478707 | |
| us-gaap | DeferredTaxAssetsGrossNoncurrent | Deferred Tax Assets, Gross, Noncurrent | USD | 49.10M | 2015-12-31 | 2015 | FY | 10-K | 2016-02-26 | 0001193125-16-478707 | |
| us-gaap | DeferredTaxAssetsInvestmentInSubsidiaries | Deferred Tax Assets, Investment in Subsidiaries | USD | 239.10M | 2020-12-31 | 2021 | FY | 10-K | 2022-03-01 | 0001564590-22-007930 | |
| us-gaap | DeferredTaxAssetsLiabilitiesNet | Deferred Tax Assets, Net | USD | 4.73M | 2023-12-31 | 2024 | FY | 10-K | 2025-02-27 | 0000950170-25-029095 | |
| us-gaap | DeferredTaxAssetsNet | Deferred Tax Assets, Net of Valuation Allowance | USD | 151.27M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-078266 | |
| us-gaap | DeferredTaxAssetsNetCurrent | Deferred Tax Assets, Net of Valuation Allowance, Current | USD | 20.16M | 2014-12-31 | 2015 | FY | 10-K | 2016-02-26 | 0001193125-16-478707 | |
| us-gaap | DeferredTaxAssetsNetNoncurrent | Deferred Tax Assets, Net of Valuation Allowance, Noncurrent | USD | 3.31M | 2020-03-31 | 2020 | Q1 | 10-Q | 2020-05-05 | 0001564590-20-021269 | |
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwardsDomestic | Deferred Tax Assets, Operating Loss Carryforwards, Domestic | USD | 0 | 2023-12-31 | 2023 | FY | 10-K | 2024-02-28 | 0000950170-24-022057 | |
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwardsForeign | Deferred Tax Assets, Operating Loss Carryforwards, Foreign | USD | 100,000 | 2023-12-31 | 2023 | FY | 10-K | 2024-02-28 | 0000950170-24-022057 | |
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal | Deferred Tax Assets, Operating Loss Carryforwards, State and Local | USD | 671.00M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-078266 | |
| us-gaap | DeferredTaxAssetsOther | Deferred Tax Assets, Other | USD | 5.26M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-078266 | |
| us-gaap | DeferredTaxAssetsPropertyPlantAndEquipment | Deferred Tax Assets, Property, Plant and Equipment | USD | 11.13M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-078266 | |
| us-gaap | DeferredTaxAssetsTaxCreditCarryforwards | Deferred Tax Assets, Tax Credit Carryforwards | USD | 1.40M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-078266 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits | Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits | USD | 18.55M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-078266 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPensions | Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Pensions | USD | 724,000 | 2019-12-31 | 2019 | FY | 10-K | 2020-02-28 | 0001564590-20-007769 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts | Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Allowance for Doubtful Accounts | USD | 1.45M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-078266 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLegalSettlements | Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Legal Settlements | USD | 38.60M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-078266 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsSelfInsurance | Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Self Insurance | USD | 172,000 | 2012-12-31 | 2012 | FY | 10-K | 2013-03-01 | 0001193125-13-087740 | |
| us-gaap | DeferredTaxAssetsValuationAllowance | Deferred Tax Assets, Valuation Allowance | USD | 269.37M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-078266 | |
| us-gaap | DeferredTaxExpenseFromStockOptionsExercised | Deferred Tax Expense from Stock Options Exercised | USD | 300,000 | 2015-01-01 | 2015-12-31 | 2016 | FY | 10-K | 2017-02-24 | 0001193125-17-056016 |
| us-gaap | DeferredTaxLiabilities | Deferred Tax Liabilities, Net | USD | 64.08M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-078266 | |
| us-gaap | DeferredTaxLiabilitiesDeferredExpenseReservesAndAccruals | Deferred Tax Liabilities, Deferred Expense, Reserves and Accruals | USD | 4.53M | 2016-12-31 | 2017 | FY | 10-K | 2018-02-27 | 0001193125-18-061152 | |
| us-gaap | DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets | Deferred Tax Liabilities, Intangible Assets | USD | 176.26M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-078266 | |
| us-gaap | DeferredTaxLiabilitiesGrossNoncurrent | Deferred Tax Liabilities, Gross, Noncurrent | USD | 23.90M | 2015-12-31 | 2015 | FY | 10-K | 2016-02-26 | 0001193125-16-478707 | |
| us-gaap | DeferredTaxLiabilitiesNoncurrent | Deferred Tax Liabilities, Net, Noncurrent | USD | 85.41M | 2020-03-31 | 2020 | Q1 | 10-Q | 2020-05-05 | 0001564590-20-021269 | |
| us-gaap | DeferredTaxLiabilitiesOther | Deferred Tax Liabilities, Other | USD | 12.79M | 2019-12-31 | 2020 | FY | 10-K | 2021-02-26 | 0001564590-21-009466 | |
| us-gaap | DeferredTaxLiabilitiesPrepaidExpenses | Deferred Tax Liabilities, Prepaid Expenses | USD | 6.33M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-078266 | |
| us-gaap | DeferredTaxLiabilitiesPropertyPlantAndEquipment | Deferred Tax Liabilities, Property, Plant and Equipment | USD | 2.46M | 2021-12-31 | 2022 | FY | 10-K | 2023-02-28 | 0001564590-23-002737 | |
| us-gaap | DefinedBenefitPensionPlanCurrentAndNoncurrentLiabilities | Liability, Defined Benefit Pension Plan | USD | 6.30M | 2014-09-30 | 2014 | Q3 | 10-Q | 2014-10-30 | 0001193125-14-389873 | |
| us-gaap | DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax | Defined Benefit Plan, Accumulated Other Comprehensive (Income) Loss, before Tax | USD | -4.10M | 2017-12-31 | 2017 | FY | 10-K | 2018-02-27 | 0001193125-18-061152 | |
| us-gaap | DefinedBenefitPlanActuarialGainLoss | Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss) | USD | 2.76M | 2014-01-01 | 2014-12-31 | 2014 | FY | 10-K | 2015-02-27 | 0001193125-15-069793 |
| us-gaap | DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate | Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Discount Rate | pure | 0.038 | 2015-12-31 | 2015 | FY | 10-K | 2016-02-26 | 0001193125-16-478707 | |
| us-gaap | DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease | Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Rate of Compensation Increase | pure | 0.034 | 2014-12-31 | 2015 | FY | 10-K | 2016-02-26 | 0001193125-16-478707 | |
| us-gaap | DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate | Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate | pure | 0.019 | 2019-01-01 | 2019-12-31 | 2019 | FY | 10-K | 2020-02-28 | 0001564590-20-007769 |
| us-gaap | DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets | Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-term Rate of Return on Plan Assets | pure | 0.019 | 2019-01-01 | 2019-12-31 | 2019 | FY | 10-K | 2020-02-28 | 0001564590-20-007769 |
| us-gaap | DefinedBenefitPlanBenefitObligation | Defined Benefit Plan, Benefit Obligation | USD | 58.11M | 2015-12-31 | 2015 | FY | 10-K | 2016-02-26 | 0001193125-16-478707 | |
| us-gaap | DefinedBenefitPlanBenefitsPaid | Defined Benefit Plan, Benefits Paid (Deprecated 2017-01-31) | USD | 729,000 | 2014-01-01 | 2014-12-31 | 2014 | FY | 10-K | 2015-02-27 | 0001193125-15-069793 |
| us-gaap | DefinedBenefitPlanContributionsByEmployer | Defined Benefit Plan, Plan Assets, Contributions by Employer | USD | 825,000 | 2014-01-01 | 2014-12-31 | 2014 | FY | 10-K | 2015-02-27 | 0001193125-15-069793 |
| us-gaap | DefinedBenefitPlanCurtailments | Defined Benefit Plan, Benefit Obligation, (Increase) Decrease for Curtailment | USD | 1.37M | 2015-01-01 | 2015-12-31 | 2015 | FY | 10-K | 2016-02-26 | 0001193125-16-478707 |
| us-gaap | DefinedBenefitPlanExpectedReturnOnPlanAssets | Defined Benefit Plan, Expected Return (Loss) on Plan Assets | USD | 2.03M | 2015-01-01 | 2015-12-31 | 2015 | FY | 10-K | 2016-02-26 | 0001193125-16-478707 |
| us-gaap | DefinedBenefitPlanFairValueOfPlanAssets | Defined Benefit Plan, Plan Assets, Amount | USD | 55.29M | 2015-12-31 | 2015 | FY | 10-K | 2016-02-26 | 0001193125-16-478707 | |
| us-gaap | DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation | Defined Benefit Plan, Benefit Obligation, Foreign Currency Translation Gain (Loss) | USD | -710,000 | 2014-01-01 | 2014-12-31 | 2014 | FY | 10-K | 2015-02-27 | 0001193125-15-069793 |
| us-gaap | DefinedBenefitPlanFundedStatusOfPlan | Defined Benefit Plan, Funded (Unfunded) Status of Plan | USD | 2.82M | 2015-12-31 | 2015 | FY | 10-K | 2016-02-26 | 0001193125-16-478707 | |
| us-gaap | DefinedBenefitPlanInterestCost | Defined Benefit Plan, Interest Cost | USD | 2.37M | 2015-01-01 | 2015-12-31 | 2015 | FY | 10-K | 2016-02-26 | 0001193125-16-478707 |
| us-gaap | DefinedBenefitPlanNetPeriodicBenefitCost | Defined Benefit Plan, Net Periodic Benefit Cost (Credit) | USD | -419,000 | 2015-01-01 | 2015-12-31 | 2015 | FY | 10-K | 2016-02-26 | 0001193125-16-478707 |
| us-gaap | DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets | Defined Benefit Plan, Plan with Accumulated Benefit Obligation in Excess of Plan Assets, Plan Assets | USD | 57.36M | 2014-12-31 | 2014 | FY | 10-K | 2015-02-27 | 0001193125-15-069793 | |
| us-gaap | DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation | Defined Benefit Plan, Pension Plan with Accumulated Benefit Obligation in Excess of Plan Assets, Projected Benefit Obligation | USD | 66.91M | 2014-12-31 | 2014 | FY | 10-K | 2015-02-27 | 0001193125-15-069793 | |
| us-gaap | DefinedBenefitPlanServiceCost | Defined Benefit Plan, Service Cost | USD | -616,000 | 2015-01-01 | 2015-12-31 | 2015 | FY | 10-K | 2016-02-26 | 0001193125-16-478707 |
| us-gaap | DefinedContributionPlanEmployerDiscretionaryContributionAmount | Defined Contribution Plan, Employer Discretionary Contribution Amount | USD | 100,000 | 2016-01-01 | 2016-12-31 | 2016 | FY | 10-K | 2017-02-24 | 0001193125-17-056016 |
| us-gaap | Depreciation | Depreciation | USD | 189.20M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-078266 |
| us-gaap | DepreciationAndAmortization | Depreciation, Depletion and Amortization, Nonproduction | USD | 155.99M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447412 |
| us-gaap | DepreciationDepletionAndAmortization | Depreciation, Depletion and Amortization | USD | 7.83M | 2013-01-01 | 2013-06-30 | 2013 | Q2 | 10-Q | 2013-07-31 | 0001193125-13-312513 |
| us-gaap | DerivativeInstrumentsAndHedgesLiabilitiesNoncurrent | Derivative Instruments and Hedges, Liabilities, Noncurrent | USD | 68.92M | 2019-12-31 | 2020 | FY | 10-K | 2021-02-26 | 0001564590-21-009466 | |
| us-gaap | DerivativeInstrumentsAndHedgesNoncurrent | Derivative Instruments and Hedges, Noncurrent | USD | 60.52M | 2018-12-31 | 2019 | FY | 10-K | 2020-02-28 | 0001564590-20-007769 | |
| us-gaap | DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue | Derivative Instruments Not Designated as Hedging Instruments, Asset, at Fair Value | USD | 13.73M | 2014-06-30 | 2014 | Q2 | 10-Q | 2014-07-30 | 0001193125-14-286882 | |
| us-gaap | DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet | Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net | USD | 500,000 | 2016-01-01 | 2016-12-31 | 2016 | FY | 10-K | 2017-02-24 | 0001193125-17-056016 |
| us-gaap | DerivativeLiabilitiesCurrent | Derivative Liability, Current | USD | 84.58M | 2020-12-31 | 2021 | FY | 10-K | 2022-03-01 | 0001564590-22-007930 | |
| us-gaap | DerivativeLiabilitiesNoncurrent | Derivative Liability, Noncurrent | USD | 15.16M | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-03 | 0001193125-18-150794 | |
| us-gaap | DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax | Discontinued Operation, Gain (Loss) on Disposal of Discontinued Operation, Net of Tax | USD | -14.30M | 2021-01-01 | 2021-03-31 | 2023 | FY | 10-K | 2024-02-28 | 0000950170-24-022057 |
| us-gaap | DiscontinuedOperationTaxEffectOfDiscontinuedOperation | Discontinued Operation, Tax Effect of Discontinued Operation | USD | -88,000 | 2015-01-01 | 2015-12-31 | 2015 | FY | 10-K | 2016-02-26 | 0001193125-16-478707 |
| us-gaap | DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent | Disposal Group, Including Discontinued Operation, Assets, Noncurrent | USD | 2.53B | 2019-12-31 | 2020 | FY | 10-K | 2021-02-26 | 0001564590-21-009466 | |
| us-gaap | DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss | Disposal Group, Including Discontinued Operation, Operating Income (Loss) | USD | -200,000 | 2012-01-01 | 2012-12-31 | 2014 | FY | 10-K | 2015-02-27 | 0001193125-15-069793 |
| us-gaap | DisposalGroupIncludingDiscontinuedOperationRevenue | Disposal Group, Including Discontinued Operation, Revenue | USD | 0 | 2015-01-01 | 2015-12-31 | 2015 | FY | 10-K | 2016-02-26 | 0001193125-16-478707 |
| us-gaap | EarningsPerShareBasic | Earnings Per Share, Basic | USD/shares | 0.55 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447412 |
| us-gaap | EarningsPerShareBasicAndDiluted | Earnings Per Share, Basic and Diluted | USD/shares | 0.1 | 2012-10-01 | 2012-12-31 | 2013 | FY | 10-K | 2014-02-21 | 0001193125-14-062774 |
| us-gaap | EarningsPerShareDiluted | Earnings Per Share, Diluted | USD/shares | 0.54 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447412 |
| us-gaap | EffectiveIncomeTaxRateContinuingOperations | Effective Income Tax Rate Reconciliation, Percent | pure | 0.381 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447412 |
| us-gaap | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent | pure | 0.21 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-078266 |
| us-gaap | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent | pure | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-078266 |
| us-gaap | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent | pure | -0.032 | 2020-01-01 | 2020-12-31 | 2022 | FY | 10-K | 2023-02-28 | 0001564590-23-002737 |
| us-gaap | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent | pure | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-078266 |
| us-gaap | EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense | Effective Income Tax Rate Reconciliation, Noncontrolling Interest Income (Loss), Percent | pure | 0.006 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-078266 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Impairment Losses, Percent | pure | -0.196 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-078266 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent | pure | -0.003 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-078266 |
| us-gaap | EffectiveIncomeTaxRateReconciliationOtherAdjustments | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent | pure | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-078266 |
| us-gaap | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent | pure | -0.035 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-078266 |
| us-gaap | EffectiveIncomeTaxRateReconciliationTaxContingenciesForeign | Effective Income Tax Rate Reconciliation, Tax Contingency, Foreign, Percent | pure | 0.392 | 2016-01-01 | 2016-12-31 | 2018 | FY | 10-K | 2019-03-01 | 0001564590-19-005750 |
| us-gaap | EffectiveIncomeTaxRateReconciliationTaxCredits | Effective Income Tax Rate Reconciliation, Tax Credit, Percent | pure | -0.004 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-078266 |
| us-gaap | EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent | Effective Income Tax Rate Reconciliation, Tax Cuts and Jobs Act, Percent | pure | -16.4 | 2018-01-01 | 2018-12-31 | 2020 | FY | 10-K | 2021-02-26 | 0001564590-21-009466 |
| us-gaap | EffectOfExchangeRateOnCashAndCashEquivalents | Effect of Exchange Rate on Cash and Cash Equivalents | USD | -221,000 | 2019-01-01 | 2019-06-30 | 2019 | Q2 | 10-Q | 2019-07-31 | 0001564590-19-027472 |
| us-gaap | EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations | USD | 4.07M | 2021-01-01 | 2021-12-31 | 2023 | FY | 10-K | 2024-02-28 | 0000950170-24-022057 |
| us-gaap | EmployeeRelatedLiabilitiesCurrent | Employee-related Liabilities, Current | USD | 184.39M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447412 | |
| us-gaap | EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards | Share-based Payment Arrangement, Cash Used to Settle Award | USD | 1.03M | 2011-01-01 | 2011-12-31 | 2013 | FY | 10-K | 2014-02-21 | 0001193125-14-062774 |
| us-gaap | EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense | Share-based Payment Arrangement, Expense, Tax Benefit | USD | 8.02M | 2015-01-01 | 2015-09-30 | 2015 | Q3 | 10-Q | 2015-11-04 | 0001193125-15-366114 |
| us-gaap | EquityMethodInvestmentOwnershipPercentage | Equity Method Investment, Ownership Percentage | pure | 1 | 2014-06-30 | 2014 | Q2 | 10-Q | 2014-07-30 | 0001193125-14-286882 | |
| us-gaap | ExcessTaxBenefitFromShareBasedCompensationFinancingActivities | Excess Tax Benefit from Share-based Compensation, Financing Activities | USD | 309,000 | 2015-01-01 | 2015-12-31 | 2017 | FY | 10-K | 2018-02-27 | 0001193125-18-061152 |
| us-gaap | ExtinguishmentOfDebtAmount | Extinguishment of Debt, Amount | USD | 9.35M | 2013-01-01 | 2013-09-30 | 2014 | Q3 | 10-Q | 2014-10-30 | 0001193125-14-389873 |
| us-gaap | FairValueOfAssetsAcquired | Fair Value of Assets Acquired | USD | 33.59M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447412 |
| us-gaap | FinanceLeaseInterestExpense | Finance Lease, Interest Expense | USD | 999,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-078266 |
| us-gaap | FinanceLeaseInterestPaymentOnLiability | Finance Lease, Interest Payment on Liability | USD | 999,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-078266 |
| us-gaap | FinanceLeaseLiability | Finance Lease, Liability | USD | 11.80M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-078266 | |
| us-gaap | FinanceLeaseLiabilityCurrent | Finance Lease, Liability, Current | USD | 1.09M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447412 | |
| us-gaap | FinanceLeaseLiabilityNoncurrent | Finance Lease, Liability, Noncurrent | USD | 10.71M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-078266 | |
| us-gaap | FinanceLeaseLiabilityPaymentsDue | Finance Lease, Liability, Payment, Due | USD | 24.00M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-078266 | |
| us-gaap | FinanceLeaseLiabilityPaymentsDueAfterYearFive | Finance Lease, Liability, to be Paid, after Year Five | USD | 18.43M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-078266 | |
| us-gaap | FinanceLeaseLiabilityPaymentsDueNextTwelveMonths | Finance Lease, Liability, to be Paid, Year One | USD | 1.09M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-078266 | |
| us-gaap | FinanceLeaseLiabilityPaymentsDueYearFive | Finance Lease, Liability, to be Paid, Year Five | USD | 1.20M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-078266 | |
| us-gaap | FinanceLeaseLiabilityPaymentsDueYearFour | Finance Lease, Liability, to be Paid, Year Four | USD | 1.11M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-078266 | |
| us-gaap | FinanceLeaseLiabilityPaymentsDueYearThree | Finance Lease, Liability, to be Paid, Year Three | USD | 1.09M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-078266 | |
| us-gaap | FinanceLeaseLiabilityPaymentsDueYearTwo | Finance Lease, Liability, to be Paid, Year Two | USD | 1.09M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-078266 | |
| us-gaap | FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear | Finance Lease, Liability, to be Paid, Remainder of Fiscal Year | USD | 1.96M | 2020-09-30 | 2020 | Q3 | 10-Q | 2020-10-30 | 0001564590-20-049309 | |
| us-gaap | FinanceLeaseLiabilityUndiscountedExcessAmount | Finance Lease, Liability, Undiscounted Excess Amount | USD | 12.20M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-078266 | |
| us-gaap | FinanceLeasePrincipalPayments | Finance Lease, Principal Payments | USD | 31.14M | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-01 | 0001564590-22-007930 |
| us-gaap | FinanceLeaseRightOfUseAsset | Finance Lease, Right-of-Use Asset, after Accumulated Amortization | USD | 7.05M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-078266 | |
| us-gaap | FinanceLeaseRightOfUseAssetAmortization | Finance Lease, Right-of-Use Asset, Amortization | USD | 375,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-078266 |
| us-gaap | FinanceLeaseWeightedAverageDiscountRatePercent | Finance Lease, Weighted Average Discount Rate, Percent | pure | 0.051 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-078266 | |
| us-gaap | FiniteLivedIntangibleAssetsAccumulatedAmortization | Finite-Lived Intangible Assets, Accumulated Amortization | USD | 1.13M | 2020-12-31 | 2020 | FY | 10-K | 2021-02-26 | 0001564590-21-009466 | |
| us-gaap | FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths | Finite-Lived Intangible Assets, Amortization Expense, Next Rolling Twelve Months | USD | 400,000 | 2016-09-30 | 2016 | Q3 | 10-Q | 2016-11-02 | 0001193125-16-757061 | |
| us-gaap | FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths | Finite-Lived Intangible Asset, Expected Amortization, Year One | USD | 500,000 | 2014-06-30 | 2014 | Q2 | 10-Q | 2014-07-30 | 0001193125-14-286882 | |
| us-gaap | FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear | Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year | USD | 500,000 | 2015-09-30 | 2015 | Q3 | 10-Q | 2015-11-04 | 0001193125-15-366114 | |
| us-gaap | FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFive | Finite-Lived Intangible Assets, Amortization Expense, Rolling Year Five | USD | 0 | 2016-09-30 | 2016 | Q3 | 10-Q | 2016-11-02 | 0001193125-16-757061 | |
| us-gaap | FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFour | Finite-Lived Intangible Assets, Amortization Expense, Rolling Year Four | USD | 0 | 2016-09-30 | 2016 | Q3 | 10-Q | 2016-11-02 | 0001193125-16-757061 | |
| us-gaap | FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearThree | Finite-Lived Intangible Assets, Amortization Expense, Rolling Year Three | USD | 0 | 2016-09-30 | 2016 | Q3 | 10-Q | 2016-11-02 | 0001193125-16-757061 | |
| us-gaap | FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearTwo | Finite-Lived Intangible Assets, Amortization Expense, Rolling Year Two | USD | 0 | 2016-09-30 | 2016 | Q3 | 10-Q | 2016-11-02 | 0001193125-16-757061 | |
| us-gaap | FiniteLivedIntangibleAssetsAmortizationExpenseYearFive | Finite-Lived Intangible Asset, Expected Amortization, Year Five | USD | 0 | 2014-06-30 | 2014 | Q2 | 10-Q | 2014-07-30 | 0001193125-14-286882 | |
| us-gaap | FiniteLivedIntangibleAssetsAmortizationExpenseYearFour | Finite-Lived Intangible Asset, Expected Amortization, Year Four | USD | 0 | 2014-06-30 | 2014 | Q2 | 10-Q | 2014-07-30 | 0001193125-14-286882 | |
| us-gaap | FiniteLivedIntangibleAssetsAmortizationExpenseYearThree | Finite-Lived Intangible Asset, Expected Amortization, Year Three | USD | 400,000 | 2014-06-30 | 2014 | Q2 | 10-Q | 2014-07-30 | 0001193125-14-286882 | |
| us-gaap | FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo | Finite-Lived Intangible Asset, Expected Amortization, Year Two | USD | 500,000 | 2014-06-30 | 2014 | Q2 | 10-Q | 2014-07-30 | 0001193125-14-286882 | |
| us-gaap | FiniteLivedIntangibleAssetsGross | Finite-Lived Intangible Assets, Gross | USD | 1.13M | 2020-12-31 | 2020 | FY | 10-K | 2021-02-26 | 0001564590-21-009466 | |
| us-gaap | ForeignCurrencyContractAssetFairValueDisclosure | Foreign Currency Contract, Asset, Fair Value Disclosure | USD | 60.50M | 2018-12-31 | 2019 | FY | 10-K | 2020-02-28 | 0001564590-20-007769 | |
| us-gaap | ForeignCurrencyContractsLiabilityFairValueDisclosure | Foreign Currency Contracts, Liability, Fair Value Disclosure | USD | 84.60M | 2020-12-31 | 2021 | FY | 10-K | 2022-03-01 | 0001564590-22-007930 | |
| us-gaap | GainLossOnDispositionOfAssets | Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property | USD | 3.39M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447412 |
| us-gaap | GainLossOnDispositionOfIntangibleAssets | Gain (Loss) on Disposition of Intangible Assets | USD | 100,000 | 2021-10-01 | 2021-12-31 | 2023 | FY | 10-K | 2024-02-28 | 0000950170-24-022057 |
| us-gaap | GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments | Gain (Loss) on Foreign Currency Derivative Instruments Not Designated as Hedging Instruments | USD | 523,000 | 2016-01-01 | 2016-12-31 | 2018 | FY | 10-K | 2019-03-01 | 0001564590-19-005750 |
| us-gaap | GainLossOnSaleOfBusiness | Gain (Loss) on Disposition of Business | USD | -178.81M | 2016-01-01 | 2016-12-31 | 2018 | FY | 10-K | 2019-03-01 | 0001564590-19-005750 |
| us-gaap | GainLossRelatedToLitigationSettlement | Gain (Loss) Related to Litigation Settlement | USD | -13.80M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447412 |
| us-gaap | GainsLossesOnExtinguishmentOfDebt | Gain (Loss) on Extinguishment of Debt | USD | -1.27M | 2025-01-01 | 2025-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447412 |
| us-gaap | GeneralAndAdministrativeExpense | General and Administrative Expense | USD | 177.60M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-078266 |
| us-gaap | Goodwill | Goodwill | USD | 1.32B | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447412 | |
| us-gaap | GoodwillAcquiredDuringPeriod | Goodwill, Acquired During Period | USD | 19.30M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447412 |
| us-gaap | GoodwillAndIntangibleAssetImpairment | Goodwill and Intangible Asset Impairment | USD | 0 | 2019-01-01 | 2019-12-31 | 2019 | FY | 10-K | 2020-02-28 | 0001564590-20-007769 |
| us-gaap | GoodwillForeignCurrencyTranslationGainLoss | Goodwill, Foreign Currency Translation Gain (Loss) | USD | -8.67M | 2020-01-01 | 2020-09-30 | 2020 | Q3 | 10-Q | 2020-10-30 | 0001564590-20-049309 |
| us-gaap | GoodwillGross | Goodwill, Gross | USD | 2.79B | 2020-09-30 | 2020 | Q3 | 10-Q | 2020-10-30 | 0001564590-20-049309 | |
| us-gaap | GoodwillImpairedAccumulatedImpairmentLoss | Goodwill, Impaired, Accumulated Impairment Loss | USD | 325.88M | 2020-09-30 | 2020 | Q3 | 10-Q | 2020-10-30 | 0001564590-20-049309 | |
| us-gaap | GoodwillImpairmentLoss | Goodwill, Impairment Loss | USD | 996.20M | 2025-01-01 | 2025-12-31 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447412 |
| us-gaap | GoodwillOtherChanges | Goodwill, Other Changes (Deprecated 2016-01-31) | USD | -2.41M | 2016-01-01 | 2016-03-31 | 2016 | Q1 | 10-Q | 2016-04-29 | 0001193125-16-569477 |
| us-gaap | GoodwillPurchaseAccountingAdjustments | Goodwill, Purchase Accounting Adjustments | USD | 389,000 | 2025-01-01 | 2025-09-30 | 2025 | Q3 | 10-Q | 2025-11-05 | 0001193125-25-267062 |
| us-gaap | GoodwillTranslationAdjustments | Goodwill, Translation Adjustments (Deprecated 2016-01-31) | USD | -11.41M | 2016-01-01 | 2016-03-31 | 2016 | Q1 | 10-Q | 2016-04-29 | 0001193125-16-569477 |
| us-gaap | GoodwillTranslationAndPurchaseAccountingAdjustments | Goodwill, Translation and Purchase Accounting Adjustments | USD | 8.76M | 2022-01-01 | 2022-12-31 | 2023 | FY | 10-K | 2024-02-28 | 0000950170-24-022057 |
| us-gaap | GoodwillWrittenOffRelatedToSaleOfBusinessUnit | Goodwill, Written off Related to Sale of Business Unit | USD | 700,000 | 2021-10-01 | 2021-12-31 | 2023 | FY | 10-K | 2024-02-28 | 0000950170-24-022057 |
| us-gaap | HealthCareOrganizationMedicalSuppliesAndDrugsExpense | Health Care Organization, Medical Supplies and Drugs Expense (Deprecated 2018-01-31) | USD | 29.36M | 2018-01-01 | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-03 | 0001193125-18-150794 |
| us-gaap | HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts | Health Care Organization, Patient Service Revenue Provision for Bad Debts | USD | 10.15M | 2017-01-01 | 2017-03-31 | 2018 | Q1 | 10-Q | 2018-05-03 | 0001193125-18-150794 |
| us-gaap | HealthCareOrganizationRevenue | Health Care Organization, Revenue (Deprecated 2018-01-31) | USD | 742.24M | 2018-01-01 | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-03 | 0001193125-18-150794 |
| us-gaap | HealthCareOrganizationRevenueNetOfPatientServiceRevenueProvisions | Health Care Organization, Revenue Net of Patient Service Revenue Provisions | USD | 2.27B | 2018-01-01 | 2018-09-30 | 2018 | Q3 | 10-Q | 2018-11-06 | 0001564590-18-027458 |
| us-gaap | ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill | Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) | USD | 300,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-078266 |
| us-gaap | ImpairmentOfLongLivedAssetsHeldForUse | Impairment of Long-Lived Assets Held-for-use | USD | 0 | 2024-10-01 | 2024 | FY | 10-K | 2025-02-27 | 0000950170-25-029095 | |
| us-gaap | ImpairmentOfLongLivedAssetsToBeDisposedOf | Impairment of Long-Lived Assets to be Disposed of | USD | 1.10M | 2021-07-01 | 2021-09-30 | 2023 | FY | 10-K | 2024-02-28 | 0000950170-24-022057 |
| us-gaap | IncomeLossFromContinuingOperations | Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent | USD | -21.67M | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-02-28 | 0000950170-24-022057 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | USD | 89.44M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447412 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments | Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest | USD | 32.48M | 2016-01-01 | 2016-03-31 | 2016 | Q1 | 10-Q | 2016-04-29 | 0001193125-16-569477 |
| us-gaap | IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest | USD | -15.66M | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-02-28 | 0000950170-24-022057 |
| us-gaap | IncomeLossFromContinuingOperationsPerBasicShare | Income (Loss) from Continuing Operations, Per Basic Share | USD/shares | -0.24 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-02-28 | 0000950170-24-022057 |
| us-gaap | IncomeLossFromContinuingOperationsPerDilutedShare | Income (Loss) from Continuing Operations, Per Diluted Share | USD/shares | -0.24 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-02-28 | 0000950170-24-022057 |
| us-gaap | IncomeLossFromDiscontinuedOperationsNetOfTax | Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest | USD | -12.64M | 2021-01-01 | 2021-12-31 | 2023 | FY | 10-K | 2024-02-28 | 0000950170-24-022057 |
| us-gaap | IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity | Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent | USD | -12.64M | 2021-01-01 | 2021-12-31 | 2023 | FY | 10-K | 2024-02-28 | 0000950170-24-022057 |
| us-gaap | IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare | Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share | USD/shares | -0.14 | 2021-01-01 | 2021-12-31 | 2023 | FY | 10-K | 2024-02-28 | 0000950170-24-022057 |
| us-gaap | IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare | Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Diluted Share | USD/shares | -0.14 | 2021-01-01 | 2021-12-31 | 2023 | FY | 10-K | 2024-02-28 | 0000950170-24-022057 |
| us-gaap | IncomeLossFromEquityMethodInvestments | Income (Loss) from Equity Method Investments | USD | 0 | 2014-01-01 | 2014-09-30 | 2014 | Q3 | 10-Q | 2014-10-30 | 0001193125-14-389873 |
| us-gaap | IncomeTaxesPaidNet | Income Taxes Paid, Net | USD | 30.09M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-078266 |
| us-gaap | IncomeTaxesReceivable | Income Taxes Receivable, Current | USD | 39.12M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447412 | |
| us-gaap | IncomeTaxExaminationPenaltiesAndInterestExpense | Income Tax Examination, Penalties and Interest Expense | USD | 300,000 | 2015-01-01 | 2015-12-31 | 2015 | FY | 10-K | 2016-02-26 | 0001193125-16-478707 |
| us-gaap | IncomeTaxExpenseBenefit | Income Tax Expense (Benefit) | USD | 34.06M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447412 |
| us-gaap | IncomeTaxPaidFederalAfterRefundReceived | IncomeTaxPaidFederalAfterRefundReceived | USD | 22.00M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-078266 |
| us-gaap | IncomeTaxPaidForeignAfterRefundReceived | IncomeTaxPaidForeignAfterRefundReceived | USD | 481,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-078266 |
| us-gaap | IncomeTaxReceivable | Income Taxes Receivable | USD | 41.90M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-078266 | |
| us-gaap | IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount | USD | -69,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-078266 |
| us-gaap | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount | USD | 116,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-078266 |
| us-gaap | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount | USD | -223.85M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-078266 |
| us-gaap | IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Impairment Losses, Amount | USD | 209.20M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-078266 |
| us-gaap | IncomeTaxReconciliationNondeductibleExpenseOther | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount | USD | 3.80M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-078266 |
| us-gaap | IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount | USD | -714,000 | 2012-01-01 | 2012-12-31 | 2012 | FY | 10-K | 2013-03-01 | 0001193125-13-087740 |
| us-gaap | IncomeTaxReconciliationOtherAdjustments | Effective Income Tax Rate Reconciliation, Other Adjustments, Amount | USD | -93,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-078266 |
| us-gaap | IncomeTaxReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount | USD | 36.82M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-078266 |
| us-gaap | IncomeTaxReconciliationTaxCredits | Effective Income Tax Rate Reconciliation, Tax Credit, Amount | USD | 4.71M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-078266 |
| us-gaap | IncreaseDecreaseInAccountsPayable | Increase (Decrease) in Accounts Payable | USD | 5.69M | 2011-01-01 | 2011-09-30 | 2011 | Q3 | 10-Q | 2011-11-14 | 0001193125-11-311297 |
| us-gaap | IncreaseDecreaseInAccountsPayableAndAccruedLiabilities | Increase (Decrease) in Accounts Payable and Accrued Liabilities | USD | 36.31M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447412 |
| us-gaap | IncreaseDecreaseInAccountsReceivable | Increase (Decrease) in Accounts Receivable | USD | 60.78M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447412 |
| us-gaap | IncreaseDecreaseInEmployeeRelatedLiabilities | Increase (Decrease) in Employee Related Liabilities | USD | -10.14M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447412 |
| us-gaap | IncreaseDecreaseInOtherAccruedLiabilities | Increase (Decrease) in Other Accrued Liabilities | USD | 544,000 | 2011-01-01 | 2011-09-30 | 2011 | Q3 | 10-Q | 2011-11-14 | 0001193125-11-311297 |
| us-gaap | IncreaseDecreaseInOtherCurrentAssets | Increase (Decrease) in Other Current Assets | USD | -43.99M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447412 |
| us-gaap | IncreaseDecreaseInOtherCurrentLiabilities | Increase (Decrease) in Other Current Liabilities | USD | 35.43M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447412 |
| us-gaap | IncreaseDecreaseInOtherNoncurrentAssets | Increase (Decrease) in Other Noncurrent Assets | USD | 1.98M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447412 |
| us-gaap | IncreaseDecreaseInOtherOperatingAssets | Increase (Decrease) in Other Operating Assets | USD | -661,000 | 2019-01-01 | 2019-06-30 | 2019 | Q2 | 10-Q | 2019-07-31 | 0001564590-19-027472 |
| us-gaap | IndefiniteLivedIntangibleAssetsExcludingGoodwill | Indefinite-lived Intangible Assets (Excluding Goodwill) | USD | 100.19M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447412 | |
| us-gaap | IndefiniteLivedIntangibleAssetsPurchaseAccountingAdjustments | Indefinite-lived Intangible Assets, Purchase Accounting Adjustments | USD | -40,000 | 2020-01-01 | 2020-09-30 | 2020 | Q3 | 10-Q | 2020-10-30 | 0001564590-20-049309 |
| us-gaap | InsuranceReceivableForMalpractice | Insurance Receivable for Malpractice | USD | 25.20M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447412 | |
| us-gaap | InsuranceReceivableForMalpracticeCurrent | Insurance Receivable for Malpractice, Current | USD | 222,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447412 | |
| us-gaap | InsuranceReceivableForMalpracticeNoncurrent | Insurance Receivable for Malpractice, Noncurrent | USD | 25.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447412 | |
| us-gaap | InsuranceSettlementsReceivableCurrent | Insurance Settlements Receivable, Current | USD | 3.35M | 2012-12-31 | 2012 | FY | 10-K | 2013-03-01 | 0001193125-13-087740 | |
| us-gaap | IntangibleAssetsGrossExcludingGoodwill | Intangible Assets, Gross (Excluding Goodwill) | USD | 74.27M | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-10-30 | 0000950170-24-119044 | |
| us-gaap | IntangibleAssetsNetExcludingGoodwill | Intangible Assets, Net (Excluding Goodwill) | USD | 100.19M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447412 | |
| us-gaap | InterestExpense | Interest Expense | USD | 27.67M | 2013-01-01 | 2013-09-30 | 2013 | Q3 | 10-Q | 2013-10-30 | 0001193125-13-418667 |
| us-gaap | InterestIncomeExpenseNet | Interest Income (Expense), Net | USD | -113.79M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447412 |
| us-gaap | InterestPaid | Interest Paid, Including Capitalized Interest, Operating and Investing Activities | USD | 175.20M | 2018-01-01 | 2018-12-31 | 2018 | FY | 10-K | 2019-03-01 | 0001564590-19-005750 |
| us-gaap | InterestPaidNet | Interest Paid, Excluding Capitalized Interest, Operating Activities | USD | 124.66M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-078266 |
| us-gaap | InterestPayableCurrent | Interest Payable, Current | USD | 19.16M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447412 | |
| us-gaap | InterestPayableCurrentAndNoncurrent | Interest Payable | USD | 5.10M | 2013-12-31 | 2013 | FY | 10-K | 2014-02-21 | 0001193125-14-062774 | |
| us-gaap | InventoryNet | Inventory, Net | USD | 6.25M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447412 | |
| us-gaap | InvestmentAdvisoryFees | Investment Advisory Fees (Deprecated 2018-01-31) | USD | 350,000 | 2012-01-01 | 2012-12-31 | 2012 | FY | 10-K | 2013-03-01 | 0001193125-13-087740 |
| us-gaap | LaborAndRelatedExpense | Labor and Related Expense | USD | 1.43B | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447412 |
| us-gaap | Land | Land | USD | 430.77M | 2018-12-31 | 2018 | FY | 10-K | 2019-03-01 | 0001564590-19-005750 | |
| us-gaap | LeaseAndRentalExpense | Operating Leases, Rent Expense | USD | 28.69M | 2021-01-01 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-10-29 | 0001564590-21-052945 |
| us-gaap | LeaseCost | Lease, Cost | USD | 49.40M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-078266 |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDue | Lessee, Operating Lease, Liability, to be Paid | USD | 196.27M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-078266 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive | Lessee, Operating Lease, Liability, to be Paid, after Year Five | USD | 81.94M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-078266 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths | Lessee, Operating Lease, Liability, to be Paid, Year One | USD | 28.16M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-078266 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearFive | Lessee, Operating Lease, Liability, to be Paid, Year Five | USD | 16.41M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-078266 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearFour | Lessee, Operating Lease, Liability, to be Paid, Year Four | USD | 20.25M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-078266 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearThree | Lessee, Operating Lease, Liability, to be Paid, Year Three | USD | 23.27M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-078266 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearTwo | Lessee, Operating Lease, Liability, to be Paid, Year Two | USD | 26.25M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-078266 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear | Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year | USD | 15.77M | 2020-09-30 | 2020 | Q3 | 10-Q | 2020-10-30 | 0001564590-20-049309 | |
| us-gaap | LesseeOperatingLeaseLiabilityUndiscountedExcessAmount | Lessee, Operating Lease, Liability, Undiscounted Excess Amount | USD | 53.15M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-078266 | |
| us-gaap | Liabilities | Liabilities | USD | 3.30B | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447412 | |
| us-gaap | LiabilitiesAndStockholdersEquity | Liabilities and Equity | USD | 5.55B | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447412 | |
| us-gaap | LiabilitiesAssumed1 | Liabilities Assumed | USD | 1.19M | 2025-01-01 | 2025-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447412 |
| us-gaap | LiabilitiesCurrent | Liabilities, Current | USD | 552.03M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447412 | |
| us-gaap | LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent | Disposal Group, Including Discontinued Operation, Liabilities, Current | USD | 660.03M | 2020-12-31 | 2021 | FY | 10-K | 2022-03-01 | 0001564590-22-007930 | |
| us-gaap | LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent | Disposal Group, Including Discontinued Operation, Liabilities, Noncurrent | USD | 487.08M | 2019-12-31 | 2020 | FY | 10-K | 2021-02-26 | 0001564590-21-009466 | |
| us-gaap | LimitedPartnersCapitalAccountDistributionAmount | Limited Partners' Capital Account, Distribution Amount | USD | 375,000 | 2011-01-01 | 2011-12-31 | 2013 | FY | 10-K | 2014-02-21 | 0001193125-14-062774 |
| us-gaap | LineOfCreditFacilityIncreaseAdditionalBorrowings | Line of Credit Facility, Increase, Additional Borrowings (Deprecated 2013-01-31) | USD | 50.00M | 2013-01-01 | 2013-03-31 | 2013 | Q1 | 10-Q | 2013-05-02 | 0001193125-13-196184 |
| us-gaap | LineOfCreditFacilityIncreaseDecreaseForPeriodNet | Line of Credit Facility, Increase (Decrease), Net | USD | 0 | 2012-01-01 | 2012-09-30 | 2012 | Q3 | 10-Q | 2012-11-08 | 0001193125-12-460463 |
| us-gaap | LineOfCreditFacilityMaximumBorrowingCapacity | Line of Credit Facility, Maximum Borrowing Capacity | USD | 75.00M | 2012-09-30 | 2012 | Q3 | 10-Q | 2012-11-08 | 0001193125-12-460463 | |
| us-gaap | LineOfCreditFacilityRemainingBorrowingCapacity | Line of Credit Facility, Remaining Borrowing Capacity | USD | 135.60M | 2014-09-30 | 2014 | Q3 | 10-Q | 2014-10-30 | 0001193125-14-389873 | |
| us-gaap | LitigationSettlementAmountAwardedToOtherParty | Litigation Settlement, Amount Awarded to Other Party | USD | 400.00M | 2024-01-19 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447412 | |
| us-gaap | LitigationSettlementExpense | Litigation Settlement, Expense | USD | 6.60M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447412 |
| us-gaap | LongTermDebt | Long-term Debt | USD | 2.35B | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447412 | |
| us-gaap | LongTermDebtCurrent | Long-term Debt, Current Maturities | USD | 32.50M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447412 | |
| us-gaap | LongTermDebtFairValue | Long-term Debt, Fair Value | USD | 175.90M | 2012-09-30 | 2012 | Q3 | 10-Q | 2012-11-08 | 0001193125-12-460463 | |
| us-gaap | LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive | Long-Term Debt, Maturity, after Year Five | USD | 550.00M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-078266 | |
| us-gaap | LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths | Long-Term Debt, Maturity, Year One | USD | 28.44M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-078266 | |
| us-gaap | LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive | Long-Term Debt, Maturity, Year Five | USD | 875.25M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-078266 | |
| us-gaap | LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour | Long-Term Debt, Maturity, Year Four | USD | 535.94M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-078266 | |
| us-gaap | LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree | Long-Term Debt, Maturity, Year Three | USD | 494.69M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-078266 | |
| us-gaap | LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo | Long-Term Debt, Maturity, Year Two | USD | 32.50M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-078266 | |
| us-gaap | LongTermDebtNoncurrent | Long-term Debt, Excluding Current Maturities | USD | 2.32B | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447412 | |
| us-gaap | LossContingencyAccrualCarryingValueCurrent | Loss Contingency, Accrual, Current | USD | 19.90M | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-10-30 | 0000950170-24-119044 | |
| us-gaap | MachineryAndEquipmentGross | Machinery and Equipment, Gross | USD | 444.54M | 2018-12-31 | 2018 | FY | 10-K | 2019-03-01 | 0001564590-19-005750 | |
| us-gaap | MalpracticeInsuranceAnnualCoverageLimit | Malpractice Insurance, Annual Coverage Limit | USD | 75.00M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-078266 |
| us-gaap | MalpracticeInsuranceDeductible | Malpractice Insurance, Deductible (Deprecated 2013-01-31) | USD | 50,000 | 2012-12-31 | 2012 | FY | 10-K | 2013-03-01 | 0001193125-13-087740 | |
| us-gaap | MalpracticeInsuranceDeductible1 | Malpractice Insurance, Deductible | USD | 250,000 | 2014-01-01 | 2014-12-31 | 2014 | FY | 10-K | 2015-02-27 | 0001193125-15-069793 |
| us-gaap | MalpracticeInsuranceMaximumCoveragePerIncident | Malpractice Insurance, Maximum Coverage Per Incident | USD | 5.00M | 2022-09-01 | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-02 | 0001564590-22-036269 |
| us-gaap | MalpracticeLossContingencyAccrualUndiscounted | Malpractice Loss Contingency, Accrual, Undiscounted | USD | 214.70M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447412 | |
| us-gaap | MalpracticeLossContingencyAccrualUndiscountedCurrent | Malpractice Loss Contingency, Accrual, Undiscounted, Current | USD | 50.30M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447412 | |
| us-gaap | MalpracticeLossContingencyAccrualUndiscountedNoncurrent | Malpractice Loss Contingency, Accrual, Undiscounted, Noncurrent | USD | 164.40M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447412 | |
| us-gaap | ManagementFeeAmountPaid | Management Fee, Amount Paid (Deprecated 2013-01-31) | USD | 1.30M | 2011-01-01 | 2011-12-31 | 2012 | FY | 10-K | 2013-03-01 | 0001193125-13-087740 |
| us-gaap | MinorityInterest | Stockholders' Equity Attributable to Noncontrolling Interest | USD | 22.42M | 2017-12-31 | 2017 | FY | 10-K | 2018-02-27 | 0001193125-18-061152 | |
| us-gaap | MinorityInterestOwnershipPercentageByParent | Noncontrolling Interest, Ownership Percentage by Parent | pure | 1 | 2016-09-30 | 2016 | Q3 | 10-Q | 2016-11-02 | 0001193125-16-757061 | |
| us-gaap | NetCashProvidedByUsedInFinancingActivities | Net Cash Provided by (Used in) Financing Activities | USD | -156.02M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447412 |
| us-gaap | NetCashProvidedByUsedInFinancingActivitiesContinuingOperations | Net Cash Provided by (Used in) Financing Activities, Continuing Operations | USD | -110.90M | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-02-28 | 0001564590-23-002737 |
| us-gaap | NetCashProvidedByUsedInInvestingActivities | Net Cash Provided by (Used in) Investing Activities | USD | -135.40M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447412 |
| us-gaap | NetCashProvidedByUsedInInvestingActivitiesContinuingOperations | Net Cash Provided by (Used in) Investing Activities, Continuing Operations | USD | -305.83M | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-02-28 | 0001564590-23-002737 |
| us-gaap | NetCashProvidedByUsedInOperatingActivities | Net Cash Provided by (Used in) Operating Activities | USD | 321.48M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447412 |
| us-gaap | NetCashProvidedByUsedInOperatingActivitiesContinuingOperations | Net Cash Provided by (Used in) Operating Activities, Continuing Operations | USD | 462.34M | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-02-28 | 0000950170-24-022057 |
| us-gaap | NetIncomeLoss | Net Income (Loss) Attributable to Parent | USD | 49.52M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447412 |
| us-gaap | NetIncomeLossAttributableToNoncontrollingInterest | Net Income (Loss) Attributable to Noncontrolling Interest | USD | 5.86M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447412 |
| us-gaap | NetIncomeLossAttributableToRedeemableNoncontrollingInterest | Net Income (Loss) Attributable to Redeemable Noncontrolling Interest | USD | 5.86M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447412 |
| us-gaap | NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionQuantification | New Accounting Pronouncement or Change in Accounting Principle, Effect of Adoption, Quantification (Deprecated 2020-01-31) | USD | 8.60M | 2017-01-01 | 2017-12-31 | 2019 | FY | 10-K | 2020-02-28 | 0001564590-20-007769 |
| us-gaap | NoncontrollingInterestIncreaseFromBusinessCombination | Noncontrolling Interest, Increase from Business Combination | USD | 6.73M | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-01 | 0001564590-22-007930 |
| us-gaap | NotesAndLoansReceivableNetCurrent | Financing Receivable, after Allowance for Credit Loss, Current | USD | 11.88M | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-11-06 | 0001564590-19-041035 | |
| us-gaap | NumberOfForeignCurrencyDerivativesHeld | Number of Foreign Currency Derivatives Held | Contract | 2 | 2014-06-30 | 2014 | FY | 10-K | 2015-02-27 | 0001193125-15-069793 | |
| us-gaap | NumberOfOperatingSegments | Number of Operating Segments | Segment | 1 | 2020-12-01 | 2020-12-31 | 2020 | FY | 10-K | 2021-02-26 | 0001564590-21-009466 |
| us-gaap | NumberOfReportableSegments | Number of Reportable Segments | Segment | 1 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447412 |
| us-gaap | NumberOfReportingUnits | Number of Reporting Units | Segment | 1 | 2024-10-01 | 2024 | FY | 10-K | 2025-02-27 | 0000950170-25-029095 | |
| us-gaap | NumberOfStatesInWhichEntityOperates | Number of States in which Entity Operates | State | 40 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447412 | |
| us-gaap | OperatingExpenses | Operating Expenses | USD | 742.95M | 2020-01-01 | 2020-03-31 | 2020 | Q1 | 10-Q | 2020-05-05 | 0001564590-20-021269 |
| us-gaap | OperatingIncomeLoss | Operating Income (Loss) | USD | 132.85M | 2020-01-01 | 2020-03-31 | 2020 | Q1 | 10-Q | 2020-05-05 | 0001564590-20-021269 |
| us-gaap | OperatingLeaseCost | Operating Lease, Cost | USD | 32.90M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-078266 |
| us-gaap | OperatingLeaseExpense | Operating Lease, Expense | USD | 35.51M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447412 |
| us-gaap | OperatingLeaseLiability | Operating Lease, Liability | USD | 143.12M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-078266 | |
| us-gaap | OperatingLeaseLiabilityCurrent | Operating Lease, Liability, Current | USD | 21.74M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447412 | |
| us-gaap | OperatingLeaseLiabilityNoncurrent | Operating Lease, Liability, Noncurrent | USD | 129.55M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447412 | |
| us-gaap | OperatingLeasePayments | Operating Lease, Payments | USD | 33.98M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-078266 |
| us-gaap | OperatingLeaseRightOfUseAsset | Operating Lease, Right-of-Use Asset | USD | 139.14M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447412 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDue | Operating Leases, Future Minimum Payments Due | USD | 1.06B | 2018-12-31 | 2018 | FY | 10-K | 2019-03-01 | 0001564590-19-005750 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueCurrent | Operating Leases, Future Minimum Payments Due, Next Twelve Months | USD | 64.96M | 2018-12-31 | 2018 | FY | 10-K | 2019-03-01 | 0001564590-19-005750 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInFiveYears | Operating Leases, Future Minimum Payments, Due in Five Years | USD | 47.68M | 2018-12-31 | 2018 | FY | 10-K | 2019-03-01 | 0001564590-19-005750 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInFourYears | Operating Leases, Future Minimum Payments, Due in Four Years | USD | 51.57M | 2018-12-31 | 2018 | FY | 10-K | 2019-03-01 | 0001564590-19-005750 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInThreeYears | Operating Leases, Future Minimum Payments, Due in Three Years | USD | 57.20M | 2018-12-31 | 2018 | FY | 10-K | 2019-03-01 | 0001564590-19-005750 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInTwoYears | Operating Leases, Future Minimum Payments, Due in Two Years | USD | 61.70M | 2018-12-31 | 2018 | FY | 10-K | 2019-03-01 | 0001564590-19-005750 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueThereafter | Operating Leases, Future Minimum Payments, Due Thereafter | USD | 777.68M | 2018-12-31 | 2018 | FY | 10-K | 2019-03-01 | 0001564590-19-005750 | |
| us-gaap | OperatingLeaseWeightedAverageDiscountRatePercent | Operating Lease, Weighted Average Discount Rate, Percent | pure | 0.065 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-078266 | |
| us-gaap | OperatingLossCarryforwardsValuationAllowance | Operating Loss Carryforwards, Valuation Allowance | USD | 239.10M | 2020-12-31 | 2020 | FY | 10-K | 2021-02-26 | 0001564590-21-009466 | |
| us-gaap | OtherAccruedLiabilitiesCurrent | Other Accrued Liabilities, Current | USD | 174.84M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447412 | |
| us-gaap | OtherAssetsCurrent | Other Assets, Current | USD | 216.62M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447412 | |
| us-gaap | OtherAssetsMiscellaneousCurrent | Other Assets, Miscellaneous, Current | USD | 5.67M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447412 | |
| us-gaap | OtherAssetsNoncurrent | Other Assets, Noncurrent | USD | 67.24M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447412 | |
| us-gaap | OtherComprehensiveIncomeDerivativesQualifyingAsHedgesTaxPortionAttributableToParent | Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Tax, Portion Attributable to Parent | USD | 16.30M | 2020-01-01 | 2020-03-31 | 2020 | Q1 | 10-Q | 2020-05-05 | 0001564590-20-021269 |
| us-gaap | OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax | Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax | USD | 19,000 | 2021-01-01 | 2021-12-31 | 2023 | FY | 10-K | 2024-02-28 | 0000950170-24-022057 |
| us-gaap | OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax | Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, Tax | USD | 100,000 | 2021-01-01 | 2021-12-31 | 2023 | FY | 10-K | 2024-02-28 | 0000950170-24-022057 |
| us-gaap | OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax | Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax | USD | -4.26M | 2021-01-01 | 2021-12-31 | 2023 | FY | 10-K | 2024-02-28 | 0000950170-24-022057 |
| us-gaap | OtherComprehensiveIncomeLossNetOfTax | Other Comprehensive Income (Loss), Net of Tax | USD | 371.37M | 2021-01-01 | 2021-12-31 | 2023 | FY | 10-K | 2024-02-28 | 0000950170-24-022057 |
| us-gaap | OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax | Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax | USD | 6.46M | 2020-01-01 | 2020-12-31 | 2022 | FY | 10-K | 2023-02-28 | 0001564590-23-002737 |
| us-gaap | OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax | Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, Tax | USD | 0 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-02-28 | 0001564590-23-002737 |
| us-gaap | OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax | Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, Net of Tax | USD | 43.75M | 2020-01-01 | 2020-03-31 | 2020 | Q1 | 10-Q | 2020-05-05 | 0001564590-20-021269 |
| us-gaap | OtherCostAndExpenseOperating | Other Cost and Expense, Operating | USD | 422.56M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447412 |
| us-gaap | OtherLiabilitiesCurrent | Other Liabilities, Current | USD | 7.82M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447412 | |
| us-gaap | OtherLiabilitiesNoncurrent | Other Liabilities, Noncurrent | USD | 207.15M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447412 | |
| us-gaap | OtherLongTermDebt | Other Long-term Debt | USD | 3.63M | 2020-12-31 | 2021 | FY | 10-K | 2022-03-01 | 0001564590-22-007930 | |
| us-gaap | OtherNoncashIncomeExpense | Other Noncash Income (Expense) | USD | -639,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447412 |
| us-gaap | OtherOperatingIncome | Other Operating Income | USD | 18.07M | 2020-07-01 | 2020-09-30 | 2021 | Q3 | 10-Q | 2021-10-29 | 0001564590-21-052945 |
| us-gaap | OtherReceivablesNetCurrent | Other Receivables, Net, Current | USD | 17.55M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447412 | |
| us-gaap | OtherSignificantNoncashTransactionValueOfConsiderationGiven1 | Other Significant Noncash Transaction, Value of Consideration Given | USD | 1.47M | 2014-01-01 | 2014-12-31 | 2016 | FY | 10-K | 2017-02-24 | 0001193125-17-056016 |
| us-gaap | OtherSundryLiabilitiesCurrent | Other Sundry Liabilities, Current | USD | 8.59M | 2016-09-30 | 2016 | Q3 | 10-Q | 2016-11-02 | 0001193125-16-757061 | |
| us-gaap | PartnersCapital | Partners' Capital | USD | 25.11M | 2010-12-31 | 2013 | FY | 10-K | 2014-02-21 | 0001193125-14-062774 | |
| us-gaap | PartnersCapitalAccountContributions | Partners' Capital Account, Contributions | USD | 51.03M | 2011-01-01 | 2011-12-31 | 2013 | FY | 10-K | 2014-02-21 | 0001193125-14-062774 |
| us-gaap | PartnersCapitalAccountUnitBasedCompensation | Partners' Capital Account, Unit-based Payment Arrangement, Amount | USD | 19.84M | 2011-01-01 | 2011-09-30 | 2011 | Q3 | 10-Q | 2011-11-14 | 0001193125-11-311297 |
| us-gaap | PartnersCapitalOther | Partners' Capital, Other | USD | -74.44M | 2011-01-01 | 2011-12-31 | 2013 | FY | 10-K | 2014-02-21 | 0001193125-14-062774 |
| us-gaap | PaymentForContingentConsiderationLiabilityFinancingActivities | Payment for Contingent Consideration Liability, Financing Activities | USD | 1.50M | 2025-01-01 | 2025-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447412 |
| us-gaap | PaymentsForProceedsFromDerivativeInstrumentInvestingActivities | Payments for (Proceeds from) Derivative Instrument, Investing Activities | USD | 84.80M | 2021-01-01 | 2021-12-31 | 2023 | FY | 10-K | 2024-02-28 | 0000950170-24-022057 |
| us-gaap | PaymentsForProceedsFromOtherInvestingActivities | Payments for (Proceeds from) Other Investing Activities | USD | 3.44M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447412 |
| us-gaap | PaymentsForRepurchaseOfCommonStock | Payments for Repurchase of Common Stock | USD | 50.03M | 2025-01-01 | 2025-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447412 |
| us-gaap | PaymentsForRepurchaseOfRedeemableNoncontrollingInterest | Payments for Repurchase of Redeemable Noncontrolling Interest | USD | 5.54M | 2022-01-01 | 2022-12-31 | 2024 | FY | 10-K | 2025-02-27 | 0000950170-25-029095 |
| us-gaap | PaymentsOfCapitalDistribution | Payments of Capital Distribution | USD | 74.44M | 2011-01-01 | 2011-12-31 | 2013 | FY | 10-K | 2014-02-21 | 0001193125-14-062774 |
| us-gaap | PaymentsOfDebtIssuanceCosts | Payments of Debt Issuance Costs | USD | 18.61M | 2025-01-01 | 2025-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447412 |
| us-gaap | PaymentsOfDistributionsToAffiliates | Payments of Distributions to Affiliates | USD | 4.21M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447412 |
| us-gaap | PaymentsOfDividendsMinorityInterest | Payments of Ordinary Dividends, Noncontrolling Interest | USD | 4.21M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447412 |
| us-gaap | PaymentsOfStockIssuanceCosts | Payments of Stock Issuance Costs | USD | 700,000 | 2016-01-12 | 2017 | FY | 10-K | 2018-02-27 | 0001193125-18-061152 | |
| us-gaap | PaymentsToAcquireBusinessesNetOfCashAcquired | Payments to Acquire Businesses, Net of Cash Acquired | USD | 8.16M | 2025-01-01 | 2025-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447412 |
| us-gaap | PaymentsToAcquirePropertyPlantAndEquipment | Payments to Acquire Property, Plant, and Equipment | USD | 165.86M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447412 |
| us-gaap | PaymentsToAcquireRealEstate | Payments to Acquire Real Estate | USD | 4.45M | 2019-01-01 | 2019-06-30 | 2019 | Q2 | 10-Q | 2019-07-31 | 0001564590-19-027472 |
| us-gaap | PreferredStockParOrStatedValuePerShare | Preferred Stock, Par or Stated Value Per Share | USD/shares | 0.01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447412 | |
| us-gaap | PreferredStockSharesAuthorized | Preferred Stock, Shares Authorized | shares | 10.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447412 | |
| us-gaap | PreferredStockSharesIssued | Preferred Stock, Shares Issued | shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447412 | |
| us-gaap | PreferredStockValue | Preferred Stock, Value, Issued | USD | 0 | 2014-06-30 | 2014 | Q2 | 10-Q | 2014-07-30 | 0001193125-14-286882 | |
| us-gaap | PrepaidExpenseCurrent | Prepaid Expense, Current | USD | 51.10M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447412 | |
| us-gaap | ProceedsAndExcessTaxBenefitFromSharebasedCompensation | Proceeds and Excess Tax Benefit from Share-based Compensation | USD | 1.21M | 2013-01-01 | 2013-06-30 | 2013 | Q2 | 10-Q | 2013-07-31 | 0001193125-13-312513 |
| us-gaap | ProceedsFromContributionsFromAffiliates | Proceeds from Contributions from Affiliates | USD | 2.76M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447412 |
| us-gaap | ProceedsFromContributionsFromParent | Proceeds from Contributions from Parent | USD | 51.03M | 2011-01-01 | 2011-12-31 | 2013 | FY | 10-K | 2014-02-21 | 0001193125-14-062774 |
| us-gaap | ProceedsFromDivestitureOfBusinesses | Proceeds from Divestiture of Businesses | USD | 1.51B | 2021-01-01 | 2021-12-31 | 2023 | FY | 10-K | 2024-02-28 | 0000950170-24-022057 |
| us-gaap | ProceedsFromDividendsReceived | Proceeds from Dividends Received | USD | 36.64M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447412 |
| us-gaap | ProceedsFromIncomeTaxRefunds | Proceeds from Income Tax Refunds | USD | 22.80M | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-01 | 0001564590-22-007930 |
| us-gaap | ProceedsFromIssuanceOfCommonStock | Proceeds from Issuance of Common Stock | USD | 216.88M | 2016-01-01 | 2016-12-31 | 2018 | FY | 10-K | 2019-03-01 | 0001564590-19-005750 |
| us-gaap | ProceedsFromIssuanceOfLongTermDebt | Proceeds from Issuance of Long-term Debt | USD | 1.20B | 2025-01-01 | 2025-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447412 |
| us-gaap | ProceedsFromIssuanceOrSaleOfEquity | Proceeds from Issuance or Sale of Equity | USD | 44.02M | 2011-01-01 | 2011-12-31 | 2013 | FY | 10-K | 2014-02-21 | 0001193125-14-062774 |
| us-gaap | ProceedsFromLinesOfCredit | Proceeds from Lines of Credit | USD | 40.00M | 2023-01-01 | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-03 | 0000950170-23-058814 |
| us-gaap | ProceedsFromLongTermLinesOfCredit | Proceeds from Long-term Lines of Credit | USD | 468.00M | 2015-01-01 | 2015-12-31 | 2015 | FY | 10-K | 2016-02-26 | 0001193125-16-478707 |
| us-gaap | ProceedsFromMinorityShareholders | Proceeds from Noncontrolling Interests | USD | 4.18M | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-02-28 | 0000950170-24-022057 |
| us-gaap | ProceedsFromPaymentsForOtherFinancingActivities | Proceeds from (Payments for) Other Financing Activities | USD | -107,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447412 |
| us-gaap | ProceedsFromRepurchaseOfEquity | Proceeds from (Repurchase of) Equity | USD | 374.43M | 2014-01-01 | 2014-12-31 | 2014 | FY | 10-K | 2015-02-27 | 0001193125-15-069793 |
| us-gaap | ProceedsFromSaleOfPropertyPlantAndEquipment | Proceeds from Sale of Property, Plant, and Equipment | USD | 33.90M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447412 |
| us-gaap | ProceedsFromStockOptionsExercised | Proceeds from Stock Options Exercised | USD | 233,000 | 2013-01-01 | 2013-09-30 | 2013 | Q3 | 10-Q | 2013-10-30 | 0001193125-13-418667 |
| us-gaap | ProfessionalAndContractServicesExpense | Professional and Contract Services Expense | USD | 20.60M | 2012-01-01 | 2012-12-31 | 2012 | FY | 10-K | 2013-03-01 | 0001193125-13-087740 |
| us-gaap | ProfessionalFees | Professional Fees | USD | 167.62M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447412 |
| us-gaap | ProfitLoss | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | USD | 55.37M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447412 |
| us-gaap | PropertyPlantAndEquipmentGross | Property, Plant and Equipment, Gross | USD | 4.19B | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447412 | |
| us-gaap | PropertyPlantAndEquipmentNet | Property, Plant and Equipment, Net | USD | 3.05B | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447412 | |
| us-gaap | ProvisionForDoubtfulAccounts | Accounts Receivable, Credit Loss Expense (Reversal) | USD | 4.49M | 2013-01-01 | 2013-03-31 | 2013 | Q1 | 10-Q | 2013-05-02 | 0001193125-13-196184 |
| us-gaap | ReclassificationsOfTemporaryToPermanentEquity | Reclassifications of Temporary to Permanent Equity | USD | 365,000 | 2011-01-01 | 2011-12-31 | 2013 | FY | 10-K | 2014-02-21 | 0001193125-14-062774 |
| us-gaap | RedeemableNoncontrollingInterestEquityCarryingAmount | Redeemable Noncontrolling Interest, Equity, Carrying Amount | USD | 229.88M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447412 | |
| us-gaap | ReinsuranceRetentionExcessRetentionAmountReinsuredPerPolicy | ReinsuranceRetentionExcessRetentionAmountReinsuredPerPolicy | USD | 10.00M | 2022-01-01 | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-02 | 0001564590-22-036269 |
| us-gaap | ReinsuranceRetentionPolicyAmountRetained | Reinsurance Retention Policy, Amount Retained | USD | 3.00M | 2017-01-01 | 2017-09-30 | 2017 | Q3 | 10-Q | 2017-10-25 | 0001193125-17-319331 |
| us-gaap | ReinsuranceRetentionPolicyExcessRetentionAmountReinsured | Reinsurance Retention Policy, Excess Retention, Amount Reinsured | USD | 75.00M | 2018-01-01 | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-03 | 0001193125-18-150794 |
| us-gaap | RepaymentsOfDebt | Repayments of Debt | USD | 1.35B | 2016-01-01 | 2016-12-31 | 2018 | FY | 10-K | 2019-03-01 | 0001564590-19-005750 |
| us-gaap | RepaymentsOfLongTermDebt | Repayments of Long-term Debt | USD | 21.92M | 2018-01-01 | 2018-12-31 | 2018 | FY | 10-K | 2019-03-01 | 0001564590-19-005750 |
| us-gaap | RepaymentsOfLongTermLinesOfCredit | Repayments of Long-term Lines of Credit | USD | 215.00M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447412 |
| us-gaap | RepaymentsOfNotesPayable | Repayments of Notes Payable | USD | 97.50M | 2015-01-01 | 2015-12-31 | 2016 | FY | 10-K | 2017-02-24 | 0001193125-17-056016 |
| us-gaap | RepaymentsOfOtherLongTermDebt | Repayments of Other Long-term Debt | USD | 3.30M | 2021-01-01 | 2021-12-31 | 2023 | FY | 10-K | 2024-02-28 | 0000950170-24-022057 |
| us-gaap | RepaymentsOfSecuredDebt | Repayments of Secured Debt | USD | 20.31M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447412 |
| us-gaap | RepaymentsOfSeniorDebt | Repayments of Senior Debt | USD | 670.86M | 2025-01-01 | 2025-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447412 |
| us-gaap | RetainedEarningsAccumulatedDeficit | Retained Earnings (Accumulated Deficit) | USD | -716.32M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447412 | |
| us-gaap | RevenueFromContractWithCustomerExcludingAssessedTax | Revenue from Contract with Customer, Excluding Assessed Tax | USD | 2.59B | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447412 |
| us-gaap | RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability | Right-of-Use Asset Obtained in Exchange for Finance Lease Liability | USD | 2.90M | 2020-01-01 | 2020-09-30 | 2020 | Q3 | 10-Q | 2020-10-30 | 0001564590-20-049309 |
| us-gaap | RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability | USD | 43.79M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-078266 |
| us-gaap | SeveranceCosts | Severance Costs (Deprecated 2013-01-31) | USD | 469,000 | 2013-01-01 | 2013-03-31 | 2013 | Q1 | 10-Q | 2013-05-02 | 0001193125-13-196184 |
| us-gaap | SeveranceCosts1 | Severance Costs | USD | 14.71M | 2017-01-01 | 2017-12-31 | 2017 | FY | 10-K | 2018-02-27 | 0001193125-18-061152 |
| us-gaap | ShareBasedCompensation | Share-based Payment Arrangement, Noncash Expense | USD | 28.19M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447412 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost | Share-based Payment Arrangement, Accelerated Cost | USD | 600,000 | 2013-01-01 | 2013-12-31 | 2013 | FY | 10-K | 2014-02-21 | 0001193125-14-062774 |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber | Share-based Compensation Arrangement by Share-based Payment Award, Accelerated Vesting, Number | shares | 20,090 | 2013-01-01 | 2013-12-31 | 2013 | FY | 10-K | 2014-02-21 | 0001193125-14-062774 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period | shares | 6,000 | 2013-01-01 | 2013-03-31 | 2013 | Q1 | 10-Q | 2013-05-02 | 0001193125-13-196184 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period | shares | 205,300 | 2013-01-01 | 2013-03-31 | 2013 | Q1 | 10-Q | 2013-05-02 | 0001193125-13-196184 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value | USD/shares | 29.09 | 2013-01-01 | 2013-03-31 | 2013 | Q1 | 10-Q | 2013-05-02 | 0001193125-13-196184 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number | shares | 476,978 | 2013-03-31 | 2013 | Q1 | 10-Q | 2013-05-02 | 0001193125-13-196184 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value | USD/shares | 21.48 | 2013-03-31 | 2013 | Q1 | 10-Q | 2013-05-02 | 0001193125-13-196184 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period | shares | 40,385 | 2013-01-01 | 2013-03-31 | 2013 | Q1 | 10-Q | 2013-05-02 | 0001193125-13-196184 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value | USD/shares | 15.73 | 2013-01-01 | 2013-03-31 | 2013 | Q1 | 10-Q | 2013-05-02 | 0001193125-13-196184 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate | pure | 0.33 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-078266 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate | pure | 0.044 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-078266 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized | Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized | shares | 18.18M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447412 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant | Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant | shares | 4.93M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447412 | |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value | USD | 3.96M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447412 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number | shares | 656,767 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447412 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price | USD/shares | 39.04 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447412 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value | USD | 7.78M | 2022-01-01 | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-02 | 0001564590-22-036269 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period | shares | 62,935 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447412 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price | USD/shares | 63.32 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447412 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | shares | 1.13M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447412 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value | USD/shares | 27.24 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-078266 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value | USD | 17.80M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447412 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number | shares | 1.57M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447412 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price | USD/shares | 24.73 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447412 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number | shares | 20,842 | 2011-11-01 | 2013 | FY | 10-K | 2014-02-21 | 0001193125-14-062774 | |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price | USD/shares | 30.63 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447412 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price | USD/shares | 11.68 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447412 |
| us-gaap | ShortTermLeaseCost | Short-term Lease, Cost | USD | 3.98M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-078266 |
| us-gaap | SponsorFees | Sponsor Fees | USD | 1.35M | 2011-01-01 | 2011-12-31 | 2013 | FY | 10-K | 2014-02-21 | 0001193125-14-062774 |
| us-gaap | StockholdersEquity | Stockholders' Equity Attributable to Parent | USD | 2.02B | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447412 | |
| us-gaap | StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest | USD | 253.56M | 2012-09-30 | 2012 | Q3 | 10-Q | 2012-11-08 | 0001193125-12-460463 | |
| us-gaap | StockIssuedDuringPeriodSharesStockOptionsExercised | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period | shares | 2,300 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447412 |
| us-gaap | StockIssuedDuringPeriodValueAcquisitions | Stock Issued During Period, Value, Acquisitions | USD | 44.02M | 2011-01-01 | 2011-12-31 | 2013 | FY | 10-K | 2014-02-21 | 0001193125-14-062774 |
| us-gaap | StockIssuedDuringPeriodValueNewIssues | Stock Issued During Period, Value, New Issues | USD | 901.98M | 2016-01-01 | 2016-12-31 | 2018 | FY | 10-K | 2019-03-01 | 0001564590-19-005750 |
| us-gaap | StockIssuedDuringPeriodValueStockOptionsExercised | Stock Issued During Period, Value, Stock Options Exercised | USD | 70,000 | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447412 |
| us-gaap | StockRepurchasedAndRetiredDuringPeriodValue | Stock Repurchased and Retired During Period, Value | USD | -4,000 | 2025-10-01 | 2025-12-31 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447412 |
| us-gaap | SuppliesExpense | Supplies Expense | USD | 91.19M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447412 |
| us-gaap | TaxBenefitFromStockOptionsExercised1 | Tax Benefit from Stock Options Exercised (Deprecated 2013-01-31) | USD | 200,000 | 2013-01-01 | 2013-03-31 | 2013 | Q1 | 10-Q | 2013-05-02 | 0001193125-13-196184 |
| us-gaap | TaxCutsAndJobsActOf2017IncompleteAccountingProvisionalIncomeTaxExpenseBenefit | Tax Cuts and Jobs Act, Incomplete Accounting, Provisional Income Tax Expense (Benefit) (Deprecated 2020-01-31) | USD | -10.50M | 2018-01-01 | 2018-03-31 | 2019 | FY | 10-K | 2020-02-28 | 0001564590-20-007769 |
| us-gaap | TaxCutsAndJobsActOf2017IncompleteAccountingTransitionTaxForAccumulatedForeignEarningsProvisionalIncomeTaxExpense | Tax Cuts and Jobs Act, Incomplete Accounting, Transition Tax for Accumulated Foreign Earnings, Provisional Income Tax Expense (Deprecated 2020-01-31) | USD | 0 | 2018-01-01 | 2018-12-31 | 2019 | FY | 10-K | 2020-02-28 | 0001564590-20-007769 |
| us-gaap | TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsLiability | Tax Cuts and Jobs Act, Transition Tax for Accumulated Foreign Earnings, Liability | USD | 0 | 2019-12-31 | 2019 | FY | 10-K | 2020-02-28 | 0001564590-20-007769 | |
| us-gaap | TaxesPayableCurrent | Taxes Payable, Current | USD | 0 | 2023-12-31 | 2023 | FY | 10-K | 2024-02-28 | 0000950170-24-022057 | |
| us-gaap | UnrecognizedTaxBenefits | Unrecognized Tax Benefits | USD | 8.74M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-078266 | |
| us-gaap | UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued | Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued | USD | 0 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-01 | 0001564590-22-007930 | |
| us-gaap | UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense | Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense | USD | 500,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-078266 |
| us-gaap | UnrecognizedTaxBenefitsIncomeTaxPenaltiesExpense | Unrecognized Tax Benefits, Income Tax Penalties Expense | USD | 48.20M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447412 |
| us-gaap | UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions | Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions | USD | 7.45M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-078266 |
| us-gaap | UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions | Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions | USD | 159,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-078266 |
| us-gaap | UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations | Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations | USD | 3.87M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-078266 |
| us-gaap | UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate | Unrecognized Tax Benefits that Would Impact Effective Tax Rate | USD | 9.00M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-078266 | |
| us-gaap | VariableLeaseCost | Variable Lease, Cost | USD | 3.88M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-078266 |
| us-gaap | WarrantsAndRightsOutstanding | Warrants and Rights Outstanding | USD | 0 | 2022-12-31 | 2022 | FY | 10-K | 2023-02-28 | 0001564590-23-002737 | |
| us-gaap | WeightedAverageNumberDilutedSharesOutstandingAdjustment | Weighted Average Number Diluted Shares Outstanding Adjustment | shares | 705,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447412 |
| us-gaap | WeightedAverageNumberOfDilutedSharesOutstanding | Weighted Average Number of Shares Outstanding, Diluted | shares | 91.45M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447412 |
| us-gaap | WeightedAverageNumberOfSharesOutstandingBasic | Weighted Average Number of Shares Outstanding, Basic | shares | 90.75M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447412 |
| us-gaap | WorkersCompensationDiscountAmount | Workers' Compensation Discount, Amount | USD | 1.86M | 2012-12-31 | 2012 | FY | 10-K | 2013-03-01 | 0001193125-13-087740 | |
| us-gaap | WorkersCompensationLiabilityCurrent | Workers' Compensation Liability, Current | USD | 18.50M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-078266 | |
| us-gaap | WorkersCompensationLiabilityNoncurrent | Workers' Compensation Liability, Noncurrent | USD | 15.80M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-078266 |